US4236893A - Method for the assay of classes of antigen-specific antibodies - Google Patents
Method for the assay of classes of antigen-specific antibodies Download PDFInfo
- Publication number
 - US4236893A US4236893A US06/028,348 US2834879A US4236893A US 4236893 A US4236893 A US 4236893A US 2834879 A US2834879 A US 2834879A US 4236893 A US4236893 A US 4236893A
 - Authority
 - US
 - United States
 - Prior art keywords
 - antibody
 - antigen
 - oscillator
 - specific
 - class
 - Prior art date
 - Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
 - Expired - Lifetime
 
Links
- 108091007433 antigens Proteins 0.000 title claims abstract description 104
 - 102000036639 antigens Human genes 0.000 title claims abstract description 104
 - 239000000427 antigen Substances 0.000 title claims abstract description 103
 - 238000000034 method Methods 0.000 title claims abstract description 53
 - 238000003556 assay Methods 0.000 title description 53
 - 230000008859 change Effects 0.000 claims abstract description 11
 - 239000013078 crystal Substances 0.000 claims description 60
 - 239000000463 material Substances 0.000 claims description 28
 - 239000003153 chemical reaction reagent Substances 0.000 claims description 18
 - 102000004169 proteins and genes Human genes 0.000 claims description 16
 - 108090000623 proteins and genes Proteins 0.000 claims description 16
 - 239000010453 quartz Substances 0.000 claims description 12
 - VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
 - 239000007788 liquid Substances 0.000 claims description 8
 - 239000013566 allergen Substances 0.000 claims description 7
 - 239000004793 Polystyrene Substances 0.000 claims description 6
 - 238000001035 drying Methods 0.000 claims description 6
 - 229920002223 polystyrene Polymers 0.000 claims description 6
 - 230000003612 virological effect Effects 0.000 claims description 5
 - 238000005406 washing Methods 0.000 claims description 5
 - 230000001580 bacterial effect Effects 0.000 claims description 4
 - 239000001273 butane Substances 0.000 claims description 4
 - 238000005259 measurement Methods 0.000 claims description 4
 - 238000002360 preparation method Methods 0.000 claims description 4
 - 238000004445 quantitative analysis Methods 0.000 claims description 3
 - 230000002538 fungal effect Effects 0.000 claims description 2
 - 230000003071 parasitic effect Effects 0.000 claims description 2
 - 239000010410 layer Substances 0.000 claims 5
 - 239000002356 single layer Substances 0.000 claims 2
 - 238000002405 diagnostic procedure Methods 0.000 claims 1
 - 239000000126 substance Substances 0.000 abstract description 6
 - 238000003127 radioimmunoassay Methods 0.000 description 16
 - 210000002966 serum Anatomy 0.000 description 16
 - 241000283973 Oryctolagus cuniculus Species 0.000 description 13
 - PZEUTLIKVUEDLB-UHFFFAOYSA-N 2-[[[2-[[6-amino-2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]propanoylamino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoylamino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(carbamoylamino)propanoyl]-(3-amino-3-oxopropyl)carbamoyl]amino]pentanediamide Chemical compound CCC(C)C(NC(=O)CN)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CNC(N)=O)C(=O)N(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O PZEUTLIKVUEDLB-UHFFFAOYSA-N 0.000 description 12
 - 239000003659 bee venom Substances 0.000 description 12
 - 229940066369 honey bee venom Drugs 0.000 description 12
 - 239000000243 solution Substances 0.000 description 12
 - 241000894007 species Species 0.000 description 10
 - 241001494479 Pecora Species 0.000 description 8
 - 238000010790 dilution Methods 0.000 description 8
 - 239000012895 dilution Substances 0.000 description 8
 - 201000005404 rubella Diseases 0.000 description 8
 - ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 7
 - 102000015439 Phospholipases Human genes 0.000 description 7
 - 108010064785 Phospholipases Proteins 0.000 description 7
 - 239000008363 phosphate buffer Substances 0.000 description 7
 - XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
 - 108060003951 Immunoglobulin Proteins 0.000 description 6
 - YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
 - 238000007654 immersion Methods 0.000 description 6
 - 102000018358 immunoglobulin Human genes 0.000 description 6
 - 239000002953 phosphate buffered saline Substances 0.000 description 6
 - 210000004027 cell Anatomy 0.000 description 5
 - 239000012153 distilled water Substances 0.000 description 5
 - 238000011534 incubation Methods 0.000 description 5
 - 230000003472 neutralizing effect Effects 0.000 description 5
 - 230000037452 priming Effects 0.000 description 5
 - 238000001179 sorption measurement Methods 0.000 description 5
 - 241000283707 Capra Species 0.000 description 4
 - 238000002965 ELISA Methods 0.000 description 4
 - SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
 - 230000000890 antigenic effect Effects 0.000 description 4
 - 239000007864 aqueous solution Substances 0.000 description 4
 - 230000027455 binding Effects 0.000 description 4
 - 230000000295 complement effect Effects 0.000 description 4
 - 238000000586 desensitisation Methods 0.000 description 4
 - LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
 - 230000035931 haemagglutination Effects 0.000 description 4
 - 230000003993 interaction Effects 0.000 description 4
 - IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
 - 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
 - 229920000084 Gum arabic Polymers 0.000 description 3
 - 239000000205 acacia gum Substances 0.000 description 3
 - 235000010489 acacia gum Nutrition 0.000 description 3
 - 229940098773 bovine serum albumin Drugs 0.000 description 3
 - 239000003795 chemical substances by application Substances 0.000 description 3
 - 238000000151 deposition Methods 0.000 description 3
 - 230000001900 immune effect Effects 0.000 description 3
 - 238000002347 injection Methods 0.000 description 3
 - 239000007924 injection Substances 0.000 description 3
 - 239000000203 mixture Substances 0.000 description 3
 - 230000035945 sensitivity Effects 0.000 description 3
 - 238000002560 therapeutic procedure Methods 0.000 description 3
 - 241000256844 Apis mellifera Species 0.000 description 2
 - LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
 - NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
 - 241001465754 Metazoa Species 0.000 description 2
 - 241000609499 Palicourea Species 0.000 description 2
 - 241000710799 Rubella virus Species 0.000 description 2
 - 241000978776 Senegalia senegal Species 0.000 description 2
 - 150000001413 amino acids Chemical class 0.000 description 2
 - 125000000129 anionic group Chemical group 0.000 description 2
 - 230000000840 anti-viral effect Effects 0.000 description 2
 - 230000004071 biological effect Effects 0.000 description 2
 - 238000004132 cross linking Methods 0.000 description 2
 - 230000008021 deposition Effects 0.000 description 2
 - 239000006185 dispersion Substances 0.000 description 2
 - 238000002474 experimental method Methods 0.000 description 2
 - 238000000760 immunoelectrophoresis Methods 0.000 description 2
 - 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
 - 238000012986 modification Methods 0.000 description 2
 - 230000004048 modification Effects 0.000 description 2
 - 238000012544 monitoring process Methods 0.000 description 2
 - 238000002810 primary assay Methods 0.000 description 2
 - 238000011160 research Methods 0.000 description 2
 - 230000004044 response Effects 0.000 description 2
 - 230000009870 specific binding Effects 0.000 description 2
 - 238000012360 testing method Methods 0.000 description 2
 - 244000171897 Acacia nilotica subsp nilotica Species 0.000 description 1
 - 208000023275 Autoimmune disease Diseases 0.000 description 1
 - 241000894006 Bacteria Species 0.000 description 1
 - 238000009007 Diagnostic Kit Methods 0.000 description 1
 - 241001397104 Dima Species 0.000 description 1
 - 101710107327 Endochitinase 1 Proteins 0.000 description 1
 - 102000004190 Enzymes Human genes 0.000 description 1
 - 108090000790 Enzymes Proteins 0.000 description 1
 - 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
 - 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
 - 108090001090 Lectins Proteins 0.000 description 1
 - 102000004856 Lectins Human genes 0.000 description 1
 - 108010089814 Plant Lectins Proteins 0.000 description 1
 - FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
 - 241000191967 Staphylococcus aureus Species 0.000 description 1
 - XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
 - 241000700605 Viruses Species 0.000 description 1
 - 239000008351 acetate buffer Substances 0.000 description 1
 - 239000002253 acid Substances 0.000 description 1
 - 230000002411 adverse Effects 0.000 description 1
 - 230000002009 allergenic effect Effects 0.000 description 1
 - 230000000172 allergic effect Effects 0.000 description 1
 - 229940037003 alum Drugs 0.000 description 1
 - 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
 - WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
 - 230000003321 amplification Effects 0.000 description 1
 - 238000004458 analytical method Methods 0.000 description 1
 - 238000013459 approach Methods 0.000 description 1
 - 208000010668 atopic eczema Diseases 0.000 description 1
 - 210000003651 basophil Anatomy 0.000 description 1
 - 230000008901 benefit Effects 0.000 description 1
 - 150000001720 carbohydrates Chemical class 0.000 description 1
 - 235000014633 carbohydrates Nutrition 0.000 description 1
 - 238000012512 characterization method Methods 0.000 description 1
 - 238000010382 chemical cross-linking Methods 0.000 description 1
 - 238000004140 cleaning Methods 0.000 description 1
 - 238000012875 competitive assay Methods 0.000 description 1
 - 239000002131 composite material Substances 0.000 description 1
 - 238000007796 conventional method Methods 0.000 description 1
 - 230000002596 correlated effect Effects 0.000 description 1
 - 230000000875 corresponding effect Effects 0.000 description 1
 - 229910001873 dinitrogen Inorganic materials 0.000 description 1
 - 230000000694 effects Effects 0.000 description 1
 - 210000003754 fetus Anatomy 0.000 description 1
 - 239000007850 fluorescent dye Substances 0.000 description 1
 - 229920002313 fluoropolymer Polymers 0.000 description 1
 - 108010074605 gamma-Globulins Proteins 0.000 description 1
 - 229910001679 gibbsite Inorganic materials 0.000 description 1
 - 231100001261 hazardous Toxicity 0.000 description 1
 - 229960001340 histamine Drugs 0.000 description 1
 - 239000005556 hormone Substances 0.000 description 1
 - 229940088597 hormone Drugs 0.000 description 1
 - 230000002209 hydrophobic effect Effects 0.000 description 1
 - 229920001600 hydrophobic polymer Polymers 0.000 description 1
 - 230000008105 immune reaction Effects 0.000 description 1
 - 230000000984 immunochemical effect Effects 0.000 description 1
 - 230000000951 immunodiffusion Effects 0.000 description 1
 - 229940072221 immunoglobulins Drugs 0.000 description 1
 - 238000001727 in vivo Methods 0.000 description 1
 - 208000015181 infectious disease Diseases 0.000 description 1
 - 238000002372 labelling Methods 0.000 description 1
 - 239000002523 lectin Substances 0.000 description 1
 - 230000000670 limiting effect Effects 0.000 description 1
 - 238000004519 manufacturing process Methods 0.000 description 1
 - 239000002184 metal Substances 0.000 description 1
 - IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
 - OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
 - 229910052757 nitrogen Inorganic materials 0.000 description 1
 - 230000009871 nonspecific binding Effects 0.000 description 1
 - 238000003199 nucleic acid amplification method Methods 0.000 description 1
 - 102000039446 nucleic acids Human genes 0.000 description 1
 - 108020004707 nucleic acids Proteins 0.000 description 1
 - 150000007523 nucleic acids Chemical class 0.000 description 1
 - 210000005152 placental membrane Anatomy 0.000 description 1
 - 229920000642 polymer Polymers 0.000 description 1
 - 230000001681 protective effect Effects 0.000 description 1
 - 239000012460 protein solution Substances 0.000 description 1
 - 238000004451 qualitative analysis Methods 0.000 description 1
 - 238000010791 quenching Methods 0.000 description 1
 - 230000000171 quenching effect Effects 0.000 description 1
 - 230000002829 reductive effect Effects 0.000 description 1
 - 229920006395 saturated elastomer Polymers 0.000 description 1
 - 238000002805 secondary assay Methods 0.000 description 1
 - 238000000926 separation method Methods 0.000 description 1
 - 239000011780 sodium chloride Substances 0.000 description 1
 - 239000001488 sodium phosphate Substances 0.000 description 1
 - 239000007787 solid Substances 0.000 description 1
 - 238000010561 standard procedure Methods 0.000 description 1
 - 238000003860 storage Methods 0.000 description 1
 - 239000000725 suspension Substances 0.000 description 1
 - 210000001519 tissue Anatomy 0.000 description 1
 - 239000003053 toxin Substances 0.000 description 1
 - 231100000765 toxin Toxicity 0.000 description 1
 - 108700012359 toxins Proteins 0.000 description 1
 - UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
 - RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
 - 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
 - 235000019801 trisodium phosphate Nutrition 0.000 description 1
 
Classifications
- 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
 - G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
 - G01N33/54366—Apparatus specially adapted for solid-phase testing
 - G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
 
 - 
        
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
 - Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
 - Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
 - Y10S436/00—Chemistry: analytical and immunological testing
 - Y10S436/807—Apparatus included in process claim, e.g. physical support structures
 - Y10S436/808—Automated or kit
 
 - 
        
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
 - Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
 - Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
 - Y10S436/00—Chemistry: analytical and immunological testing
 - Y10S436/828—Protein A
 
 
Definitions
- This invention relates to a method and article for the determination and quantitation of a particular species, class or subclass of antibody that reacts with a specific antigen. This method enables one to determine how much of each class of immunoglobulin in a serum [or plasma] sample is reactive with a particular antigen.
 - antibody refers to a protein produced by the body in response to contact of the body with a foreign substance termed an "antigen". Antibodies have the specific capacity to react with or neutralize the antigen which stimulated their production. This phenomenon is the basis of humoral aspects of the mammalian immunological system.
 - Antibodies to any particular antigen may be sub-divided into classes. Each class is distinguishable from the others on the basis of differences in the primary sequence of amino acids that makes up that portion of the antibody molecule common to all classes of the antibody. This amino acid difference results in differences in isoelectric point, antigenicity, and behavior in vivo among the classes. In man, the classes are designated as IgG, IgM, IgA, IgD, and IgE.
 - Examples of differences in biological properties among classes include the ability of IgE to sensitize basophils and trigger histamine release, the ability of IgG to pass across the placental membrane in contrast to IgM which cannot pass to the fetus, and the greater efficacy of IgG and IgM for interaction with serum complement as compared with the other classes.
 - knowledge of how much of a particular class of antibody reacts with a specific antigen yields valuable information.
 - RIAs radioimmunoassays
 - RIAs require that antibodies to the various immunoglobulin classes be tagged with a radiolabel. Consequently, these reagents are very expensive, and their handling, storage and disposal are hazardous.
 - Preparation and use of radiolabeled reagents requires special licensing and the attention of specially trained personnel. These reagents are labile and their use requires highly sophisticated instrumentation.
 - RIAs necessitate extensive calculations for analysis.
 - ELISA Enzyme-Linked-Immuno-Sorbent-Assay
 - antibodies to a particular type of antigen-specific antibody are linked to an enzyme, cf. U.S. Pat. No. 3,654,090.
 - This method requires the labeling of the reagent with another molecule which can adversely affect the performance of the labelled reagent.
 - the ELISA method also suffers from a time-dependency factor in that the incubation of all the samples being assayed must be stopped after the same time interval.
 - Another disadvantage of the ELISA method is that often the colored products formed which serve to indicate the extent of the immunological reaction are unstable.
 - the present invention overcomes many of the shortcomings of prior art methods for determining antibody classes.
 - the present method uses unlabeled and unmodified antibody preparations or other specific binding reagents such as the bacterium Staphlococcus aureus or other cells which have surface receptors for certain types of immunoglobulins; protein A, the surface receptor of Staphlococcus aureus or other cell-derived molecules or receptors for specific classes of immunogloboulins; or lectins, plant products specific for certain carbohydrates as are found on different classes of antibodies.
 - These reagents are stable, inexpensive and safe to handle.
 - a major advantage of the present invention is that both the total amount of antibody in a sample specific for a particular antigen and the amount of a particular class of that antibody can be determined in the same assay. Prior art methods do not readily allow for both of these determinations in the same assay. The method results in rapid, accurate and objective measurements (quantitative as wall as qualitative) of antibody classes.
 - the essence of the invention is the use of a piezoelectric oscillator to detect types and amounts of specific classes of antibody reactive to a particular antigen when the latter is adsorbed on the surface of the oscillator.
 - a piezoelectric oscillator e.g., quartz crystal
 - the binding of an antibody to the surface of a piezoelectric oscillator, e.g., quartz crystal, which has adsorbed on its surface a layer of antigen specific for the antibody is known and has been used as a direct gravimetric assay for the amount of antibody in a liquid sample: (Shons et al, J. Biomed. Mater. Res. 6, 565-570 (1972)) and as an indirect competitive binding assay for the amount of antigen in a liquid sample. (Copending application Ser. No. 851,491, filed Nov.
 - Piezoelectric oscillators are commonly used in electronic equipment or clocks as frequency standards and controllers. Generally, they consist of a small quartz wafer (or other material), having metal electrodes deposited on either side and some means provided for making electrical contact with an oscillator circuit. When placed in such a circuit, the portion of the wafer located between the electrodes vibrates with the precise natural frequency of the wafer. A given mass coupled to the electrode of the oscillator or crystal (used interchangeably herein) causes a decrease in the initial frequency of the crystal in an amount proportional to the mass added.
 - Shons et al supra describe a direct method for measuring the amount of an antibody in a liquid sample using a piezoelectric quartz crystal. The crystal is first coated with the antigen specific for the antibody being assayed and its frequency measured. The coated crystal is then exposed to the sample containing the antibody. The change in frequency of the crystal due to antibody pickup is a direct measurement of the amount of total antibody in the sample.
 - the present invention goes beyond the assays described by Oliveria et al and Shons et al and provides a method for identifying which class of antibody has been picked up by the antigen-precoated piezoelectric oscillator.
 - the basis for the present invention is the employment of a piezoelectric oscillator in such a manner that after an antigen has been bound to the oscillator surface and the oscillator reacted with an antiserum to determine the total antigen-specific antibody content of that antiserum, one then applies a second layer of reactive material to the oscillator.
 - This reactive material or "sandwiching" layer is specifically reactive with the class or subclass of antibody that was first bound to the antigen on the oscillator surface.
 - This second or sandwiching layer has specificity for the type of antibody to be quantitated.
 - the class of antibody bound to the antigen is determined by the specificity of the sandwiching layer toward a particular antibody class or subclass.
 - the amount of that antibody class or subclass is determined by comparison with a standard curve.
 - a quantitative method for determining classes of antigen-specific antibodies comprising the steps of (1) contacting a liquid sample suspected of containing a preselected antibody with the surface of a piezoelectric oscillator having a layer of a antigen adsorbed thereon for which said antibody is specific; (2) washing and drying said oscillator; (3) measuring the frequency of said oscillator; (4) contacting said oscillator with liquid reagent containing a predetermined amount of a material reactive with a particular class of said antibody; (5) washing and drying said oscillator, and (6) measuring the change in resonance frequency (Hz) of said oscillator from said previous measurement.
 - Hz resonance frequency
 - the antigen may be attached to the oscillator by a number of conventional techniques known in the art for attaching proteins to solid supports.
 - the antigen may simply be allowed to adsorb from an aqueous solution onto the surface of the oscillator. This method is least preferred because it results in a relatively high degree of nonspecific adsorption during the assay, and sensitivity is reduced.
 - Another technique for depositing the antigen on the oscillator is by crosslinking the protein antigen with a conventional agent such as glutaraldehyde.
 - Antigens may also be bound to the oscillator by first applying a priming coat. Antigens may be deposited on hydrophobic polymer-coated oscillators (such as polystyrene or fluorinated polymers) in which case attachment occurs by dispersion force interaction.
 - hydrophobic polymer-coated oscillators such as polystyrene or fluorinated polymers
 - attachment occurs by dispersion force interaction.
 - One disadvantage with this method is that it may lead to nonspecific adsorption when the surface is exposed to additional proteins, for example, during the assay.
 - priming materials such as gum arabic which binds proteins through anionic interactions may be used.
 - priming agents for the attachment of the antigen to the oscillator is described in copending application Ser. No. 851,492, filed Nov. 14, 1977, assigned to the assignee of the present application and also incorporated herein by reference.
 - These priming agents are polymers, preferably poly(2-hydroxy-3-dimethylamino-1,4-butane) which when applied to the surface of the oscillator promote the deposition of a uniform layer of antigen on the oscillator. Nonspecific adsorption during the assay is minimized and a high degree of sensitivity is achieved.
 - the antigen is immobilized or adsorbed on the oscillator (treated or untreated) by exposing the oscillator to an aqueous solution of the antigen.
 - a simple antigen may be present in the solution or the antigen may consist of a complex mixture of molecules.
 - Optimum concentration for attachment (or adsorption) varies from antigen to antigen according to their solubility or molecular weight, however, concentrations in the range of 0.1 to 100 milligrams per milliliter are generally preferred. Attachment is accomplished preferably at room temperature and at a pH which maintains the biological activity of the antigen.
 - Optimum time for the attachment of antigens to the oscillator varies with the molecular weight and polarity of the antigen.
 - a water wash is directed into the solution and the oscillator is thoroughly washed without contacting the air. This wash procedure prevents contact of the oscillator with denatured protein at an air-protein solution interface. The oscillator is removed and allowed to dry. The frequency of the coated oscillator is then determined. The oscillator is ready to be used in an immunochemical assay.
 - the antigen-coated oscillator is stable and may be stored for extended periods of time (e.g. several months) without loss of immunological activity.
 - the solution is applied to the antigen-coated crystal surface. This may be accomplished either by immersion of the crystal in the antibody solution or by application of the antibody solution to a single side of a crystal. If a single side of an oscillator is used the other side may be separately employed for a subsequent assay.
 - This solution optimally contains antibody to the specific antigen in concentrations of 0.1 to 100 ug/ml.
 - the crystal may be incubated at temperatures preferably between 4° and 37° C. and for a period preferably ranging from 15 minutes to 24 hours.
 - the oscillator After the oscillator is washed and dried, its resonance frequency is measured. If one desires to quantify the amount of total antibody picked up by the oscillator, it is also necessary to measure the resonance frequency of the oscillator immediately prior to contacting the oscillator with the antibody solution and compare to a standard cure.
 - a solution of material specific for a select type of antibody is applied to the crystal surface in the manner and under the circumstances described above for the assay of the total amount of antigen-specific antibody.
 - the material used to characterize an antibody may be any material that binds specifically to a particular species, class or subclass of antibody. Such materials include anti-antibodies, Protein A, Staphlococcus aureus and certain lectins. Such materials must be presented to the crystal at a concentration that is in excess of that which can be bound by a crystal saturated with the first antibody.
 - Hz resonance frequency
 - the primary layer of antigen specific antibody may be quantitated in either units of ug/ml, IU/ml or reciprocals of dilution, i.e., titer.
 - this procedure may be employed to yield data that is of value entirely on the basis of comparison of one test sample with another.
 - a convenient means for carrying out the method of the invention is to provide an immunological diagnostic kit comprising a piezoelectric oscillator having an antigen adsorbed thereon.
 - a reagent containing a predetermined amount of a reagent specifically reactive with a particular class of antibody In conjunction with the antigen oscillator composite there is provided a reagent containing a predetermined amount of a reagent specifically reactive with a particular class of antibody.
 - a sample of patient serum is contacted with the oscillator.
 - the change in frequency of the oscillator is optionally measured at this point if total antibody pick up is to be determined.
 - After washing and drying of the oscillator it is then contacted with the reagent containing the sandwiching material. Following incubation (preferably about 75 minutes) the oscillator is washed, dried, and its resonance frequency measured.
 - the change in frequency due to the attachment of the sandwiching material is directly proportional to the amount of the specific class of antibody in the serum sample.
 - Classes of antibodies to virtually all antigenic materials of clinical interest may be determined using the present invention.
 - Those of particular interest include antibodies to allergens such as honey bee venom; antibodies to viral antigens; antibodies to autoantigens, i.e., to nucleic acids, to gamma globulins, to hormones or to tissue specific antigens; antibodies specific to bacterial antigens or bacterial products such as toxins and antibodies to fungal or parasitic antigens or products of these organisms.
 - the procedure followed for this sandwich assay begins with the cleaning of the quartz crystal oscillators.
 - the crystals are cleaned either by immersion in a 10% aqueous solution of trisodium phosphate for 1 hour at 20° C. with subsequent rinsing in distilled water or by immersion in trichloroethylene for 30 seconds followed by 5 consecutive rinses of 5 seconds each in distilled water then immersion in an ultrasonic bath containing 190 proof ethanol for 15 to 45 minutes and drying under a stream of dry nitrogen gas.
 - the crystals were then treated with the primer poly(2-hydroxy-3-dimethylamino-1,4 butane) (DIMA) by immersion in an 0.08% aqueous solution thereof for 18 hours at 20° C. Following rinsing with distilled water, the crystals were dried.
 - DIMA primer poly(2-hydroxy-3-dimethylamino-1,4 butane)
 - quartz crystal oscillators were immersed in a solution of honey bee venom (HBV, Sigma Chemical Company, St. Louis, Missouri) at a concentration of 10 mg/ml in 0.02 M phosphate buffer, pH 7.0. Adsorption of the HBV occurred during a four hour incubation at 20° C. The crystals were then rinsed with distilled water, dried and their resonance frequency measured. The assay was performed by applying 50 ⁇ l aliquots of a dilution of serum of a patient who had been undergoing desensitization therapy employing injections of honey bee venom. The serum was applied to one side of a crystal held in a horizontal position. The crystals and serum were incubated for 75 minutes at 20° C. The crystals were rinsed, dried and the resonance frequency measured.
 - honey bee venom HBV, Sigma Chemical Company, St. Louis, Missouri
 - a second layer of antibody specific for human IgG class antibody was applied to the crystal surface.
 - This reagent was goat anti-human IgG (Meloy Laboratories, Inc., Springfield, Virginia) applied at a concentration of 50 g/ml in 0.02 M phosphate buffered saline, pH 7.0. This was applied in a 50 ⁇ l drop to the surface of a horizontal crystal. The crystals covered with this reagent were then incubated at 20° C. for 75 minutes, rinsed, dried and their resonance frequencies noted.
 - This same serum sample was also assayed via an RIA method to determine the concentration of IgG anti-phospholipase A antibody in ⁇ g/ml.
 - Phospholipase A is the major allergenic component of honey bee venon.
 - the results of these assays are tabulated below in Table I.
 - the change in frequency of the quartz oscillator is referred to as Hz. Shown are the Hz frequency shifts from both the primary assay for total anti-HBV antiserum and from the secondary assay for either human IgG or human IgE class antibodies as determined by the sandwich assay.
 - a second assay was performed using nine different sera samples from patients who had been desensitized to honey bee venom. It was expected that these patients would have high levels of IgG antibody to the injected allergens.
 - This assay was performed in the manner and with the reagents described in Example 1. However, in this instance, the antigen adsorbed onto the crystal surface was phospholipase A (PLA) (Sigma Chemical Company, St. Louis, Mo.). The PLA was applied as a 50 ⁇ l drop to a single side of a horizontal crystal one side at a time at a concentration of 5 mg/ml in 0.02 M phosphate buffer, pH 7.0.
 - PLA phospholipase A
 - sandwich assay yields useful data in terms of actual concentration of antibody in units such as ⁇ g/ml.
 - the method can be employed for useful clinical purposes such as monitoring the efficacy of desensitization therapy.
 - the method is equally applicable to assays of antibodies that may be directed against a single antigen or to a mixture of antigens (cf. Example 1).
 - This example illustrates the efficacy of the sandwich technique in the quantitation of different classes of specific antibodies to keyhole limpet hemocyanin in the same serum.
 - Antiserum was raised in rabbits to the antigen keyhole limpet hemocyanin (KLH, Lot. No. 730192, A. grade, Calbiochem-Behring Corp., San Diego, Calif.) by injecting the animals with 4 mg of alum (Al(OH) 3 ) precipitated KLH in 1 ml of saline intravenously. The rabbits were bled 3 days post injection and serum was collected. To assay for different classes of specific antibodies to KLH with the quartz crystal oscillators, the standard procedure was used (see example 1) except for the following modifications. KLH in solution (5 mg/ml) was incubated on the crystals for 24 hours instead of 4 hours.
 - KLH in solution 5 mg/ml
 - Incubations of antisera on the crystals were carried out for 3 hours instead of 75 minutes.
 - the antiserum used was rabbit anti-KLH and the sandwiching material was sheep anti-rabbit IgG, Fc fragment, heavy chain specific, and sheep anti-rabbit IgM, heavy chain specific (Cappel Laboratories, Inc. Cochranville, Pa.).
 - the anti-rabbit IgG used was diluted 1/10 in 0.02 M phosphate buffered saline, pH 7.0, and the anti-rabbit IgM was undiluted.
 - Anti-rabbit IgG and anti-rabbit IgM had been shown by immuno-electrophoresis and immunodiffusion to be monospecific. The following results were obtained.
 - This example illustrates the species-specific binding affinity of anti-human IgG for human IgG in the sandwich assay.
 - Honey bee venom was used as the test antigen (see example 1). Human serum with a high titer of anti-HBV activity was reacted with the crystals having HBV adsorbed thereon. Goat anti-human IgG (A102, 89373, 3.9 mg antibody/ml, Meloy Laboratories Inc., Springfield, Va.) and sheep anti-rabbit IgG were used undiluted as sandwiching layers. The following results were obtained.
 - This example illustrates that when a given class or species of antibody is not detected by the corresponding anti-antibody, the same surface of the crystal can be used to assay for a different class or species of antibody by the sandwich assay.
 - this procedure may be repeated on the same crystal surface using a secondary anti-antibody to a different class or species of antibody.
 - This example illustrates the use of the sandwich assay with anti-viral antibodies against viral antigens.
 - the sandwich assay was applied to rabbit anti-Rubella antibodies that had reacted with Rubella virus antigens adsorbed onto quartz crystals.
 - This assay was performed according to the method of example 1.
 - the antigens were either Rubella hemagglutination antigen or Rubella complement fixation antigen, or the appropriate controls. These are all products of Flow Laboratories, Inc. of Rockville, Maryland, and were used without modification.
 - the first layer antisera used was either Rubella neutralizing rabbit antiserum or rabbit preserum, also from Flow Laboratories.
 - the second layer antiserum used was sheep anti-rabbit IgG from Cappel Laboratories, Cochranville, Pa. The results are shown in Table 6.
 - sandwich assay is applicable to the characterization of antibodies directed against various types of viral antigens.
 - the parallelism between the primary and secondary (sandwich antibody) layers points to the usefulness of this technique in characterizing anti-viral antibodies and in serving as an amplification of the initial antigen-antibody reaction.
 - the present invention can be used to assay for the class of anti-Rubella virus antibody present in a patient's serum. This is useful in diagnosing the occurance of Rubella infections in pregnant women.
 - This example illustrates the use of an appropriate secondary layer other than an immunoglobulin to obtain information regarding the first layer of antibodies in the sandwich assay.
 - Protein A synthesized by the bacteria Staphylococcus aureus has been shown to bind the Fc region of IgG from several species of animals.
 - Protein A (Sigma Chemical Co., St. Louis, Mo.) at a concentration of 5 mg/ml in 0.2 M phosphate buffered saline, pH 7.0, was incubated with crystals that had varying amounts of rabbit anti-KLH bound to the KLH on their surfaces. The following results were obtained.
 - Protein A is therefore capable of binding specifically to the rabbit IgG anti-KLH on the crystals.
 - This example illustrates the use of bacterial cells with specific surface receptors as a second sandwich layer.
 - Cells with receptors on their surface specific for a particular type of antibody can also be used as a sandwich layer.
 - This layer may serve for either a qualitative or quantitative analysis of the amount and/or type of antibody bound to an antigen.
 - the crystals were prepared and assayed as described in Example 1.
 - the antigen was bovine serum albumin (BSA). (Sigma Chemical Co., St. Louis, Mo. at 10 mg/ml in phosphate buffer pH 7.0).
 - the primary anti-serum was Rabbit anti-BSA.
 - the second or sandwich layer was a 10% suspension of Staphlococcus aureus, Cowan I, ATCC 12578, grown up in CCY I media, killed, washed and suspended in PBS. This preparation was incubated on a crystal for 75 minutes at 20° C. Table 8 gives the results of this experiment.
 - these cells have protein A on their surface. This is a molecule that binds specifically to the Fc portion of the IgG antibodies of several species.
 - This example illustrates priming of the quartz crystals with polystyrene prior to deposition of the antigen coat. Proteins bind to polystyrene through dispersion forces. To demonstrate this, crystals were dipped in 1.5% polystyrene in toluene, dried with nitrogen and kept at room temperature for 24 hours to allow residual toluene to evaporate. Phospholipase A (PLA, Sigma Chemical Co. St. Louis, Mo.) an antigenic component of honey bee venon was applied at 5 mg/ml in 0.02 M phosphate buffer pH 70.
 - Phospholipase A Phospholipase A
 - the assay was performed as described in Example 1 using as the antibody source the same type of human sera samples and antihuman IgG (Meloy, Springfield, Va.) at 50 ⁇ g/ml in 0.02 M phosphate buffered saline pH 7.0.)
 - the frequency change ( ⁇ Hz) shown in Table 9 is a quantitation of phospholipase A specific-antibody of the IgG class.
 - This example illustrates that an antigen can be bound to a quartz crystal by chemical crosslinking.
 - glutaraldehyde was used to crosslink the antigen.
 - the following mixture was painted on a cleaned crystal:
 - the crystals were incubated at room temperature in a moist environment for 16 hours, and rinsed by immersion into distilled water 3 times for 1 hour.
 - a non-antigenic protein was applied to react with free glutaraldehyde remaining on the crystal.
 - bovine serum albumin Sigma Chemical Co., St. Louis, Mo. was applied at 10 mg/ml in 0.02 M phosphate buffer, pH 7.0.
 - the antibody assays were performed using the method described in Example 1 and the materials described in Example 9.
 - Table 10 illustrate that the sandwich assay can be carried out using crosslinked antigen. Although the total antibody binding ( ⁇ Hz) to phospholipase A appears to be non-specific, the sandwich assay data ( ⁇ Hz of anti-IgG) correlated well with RIA titers.
 - Table 11 illustrate that the sandwich assay can be used to characterize primary antibody layers that have bound to the antigen attached to gum arabic-primed crystals.
 
Landscapes
- Health & Medical Sciences (AREA)
 - Immunology (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - Engineering & Computer Science (AREA)
 - Molecular Biology (AREA)
 - Biomedical Technology (AREA)
 - Chemical & Material Sciences (AREA)
 - Hematology (AREA)
 - Urology & Nephrology (AREA)
 - Biotechnology (AREA)
 - Microbiology (AREA)
 - Cell Biology (AREA)
 - Food Science & Technology (AREA)
 - Medicinal Chemistry (AREA)
 - Physics & Mathematics (AREA)
 - Analytical Chemistry (AREA)
 - Biochemistry (AREA)
 - General Health & Medical Sciences (AREA)
 - General Physics & Mathematics (AREA)
 - Pathology (AREA)
 - Peptides Or Proteins (AREA)
 - Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
 
Abstract
A method and article for the determination of a particular subclass of antibody, e.g., IgA, IgE, IgM, etc., are disclosed. The method utilizes a piezoelectric oscillator having bound to the surface thereof an antigen specific for the antibody being determined. The antigen-coated oscillator is exposed to a solution containing an unknown amount of the antibody. After the antibody in the solution has attached to the antigen on the oscillator, the oscillator is exposed to a substance (sandwiching substance) which selectively binds to a specific subclass of the antibody being determined. The frequency of the oscillator is measured before and after exposure to the sandwiching substance. The change in frequency is related to the amount of the subclass of antibody bound to the oscillator, and the amount of the subclass of antibody in the solution can be quantified by reference to a standard curve.
  Description
This invention relates to a method and article for the determination and quantitation of a particular species, class or subclass of antibody that reacts with a specific antigen. This method enables one to determine how much of each class of immunoglobulin in a serum [or plasma] sample is reactive with a particular antigen.
    Generally, the term "antibody" refers to a protein produced by the body in response to contact of the body with a foreign substance termed an "antigen". Antibodies have the specific capacity to react with or neutralize the antigen which stimulated their production. This phenomenon is the basis of humoral aspects of the mammalian immunological system.
    Antibodies to any particular antigen may be sub-divided into classes. Each class is distinguishable from the others on the basis of differences in the primary sequence of amino acids that makes up that portion of the antibody molecule common to all classes of the antibody. This amino acid difference results in differences in isoelectric point, antigenicity, and behavior in vivo among the classes. In man, the classes are designated as IgG, IgM, IgA, IgD, and IgE. Examples of differences in biological properties among classes include the ability of IgE to sensitize basophils and trigger histamine release, the ability of IgG to pass across the placental membrane in contrast to IgM which cannot pass to the fetus, and the greater efficacy of IgG and IgM for interaction with serum complement as compared with the other classes. Thus, knowledge of how much of a particular class of antibody reacts with a specific antigen yields valuable information.
    There are a number of instances in the practice of diagnostic clinical immunology where it is imperative to know the amount of a particular class of antibody contained in a patient's clinical sample that reacts with a given antigen. An example is the need to know the amount of IgE vs. IgG that reacts with the allergen to which an allergic patient is sensitive and/or is being treated with desensitization injections. The level of allergen-specific IgE gives a good indication of the degree of sensitivity toward the allergen while the level of allergen-specific IgG serves as an acid in monitoring the efficacy of desensitization therapy since the IgG class is thought to be protective. In the case of assaying for Rubella antibodies in pregnant women, it is imperative to know whether the antibodies found represent a fairly recent or a past infection. The determination of the antibody class, i.e., IgM vs. IgG provides this information since IgM is only associated with the initial response to the Rubella virus while IgG is indicative of past Rubella infection. There are also several types of autoimmune disease where it is desirable to know the class of antibody involved.
    In the area of immunology research it is often a major part of an experiment to determine the class or subclass of an antibody being produced in order to gain a fuller knowledge of how an antibody-producing organism is reacting to exposure to the foreign antigenic material and how the organism will react to subsequent exposures.
    Prior to the present invention there existed several methods of antibody class determination employed by the diagnostic and/or research worker. Fundamental to these assays is the basic concept of using a second or sandwiching layer of material specific for the particular type of antibody bound to its specific antigen. These methods however suffered from a number of disadvantages. For example, radioimmunoassays (RIAs) are generally used to assay for the classes of antibodies but they have several drawbacks. RIAs require that antibodies to the various immunoglobulin classes be tagged with a radiolabel. Consequently, these reagents are very expensive, and their handling, storage and disposal are hazardous. Preparation and use of radiolabeled reagents requires special licensing and the attention of specially trained personnel. These reagents are labile and their use requires highly sophisticated instrumentation. Furthermore, RIAs necessitate extensive calculations for analysis.
    An alternative approach to RIAs has been the use of fluorescent-labeled antibodies to the specified immunoglobulin classes under study. Here again one must have specially tagged and purified immunoreagents. These fluorescent-based methods suffer from problems such as autofluorescence or quenching. In addition, the fluorescent label often makes the antibody more hydrophobic and thus prone to nonspecific binding. The results are generally of a qualitative as opposed to a quantitative nature, and their interpretation is somewhat subjective.
    Another type of assay for studying the class of antigen-specific antibody in a sample is termed ELISA (Enzyme-Linked-Immuno-Sorbent-Assay). In this method antibodies to a particular type of antigen-specific antibody are linked to an enzyme, cf. U.S. Pat. No. 3,654,090. Like the other methods mentioned above, this method requires the labeling of the reagent with another molecule which can adversely affect the performance of the labelled reagent. The ELISA method also suffers from a time-dependency factor in that the incubation of all the samples being assayed must be stopped after the same time interval. Another disadvantage of the ELISA method is that often the colored products formed which serve to indicate the extent of the immunological reaction are unstable.
    Immunoelectrophoresis of antisera against an antigen allows one to get some idea of the class of antibody that reacts with that antigen. However, the results are not readily quantitated.
    The present invention overcomes many of the shortcomings of prior art methods for determining antibody classes. The present method uses unlabeled and unmodified antibody preparations or other specific binding reagents such as the bacterium Staphlococcus aureus or other cells which have surface receptors for certain types of immunoglobulins; protein A, the surface receptor of Staphlococcus aureus or other cell-derived molecules or receptors for specific classes of immunogloboulins; or lectins, plant products specific for certain carbohydrates as are found on different classes of antibodies. These reagents are stable, inexpensive and safe to handle.
    Relatively inexpensive and unsophisticated instrumentation is required for the practice of the invention. A major advantage of the present invention is that both the total amount of antibody in a sample specific for a particular antigen and the amount of a particular class of that antibody can be determined in the same assay. Prior art methods do not readily allow for both of these determinations in the same assay. The method results in rapid, accurate and objective measurements (quantitative as wall as qualitative) of antibody classes.
    The essence of the invention is the use of a piezoelectric oscillator to detect types and amounts of specific classes of antibody reactive to a particular antigen when the latter is adsorbed on the surface of the oscillator. The binding of an antibody to the surface of a piezoelectric oscillator, e.g., quartz crystal, which has adsorbed on its surface a layer of antigen specific for the antibody is known and has been used as a direct gravimetric assay for the amount of antibody in a liquid sample: (Shons et al, J. Biomed. Mater. Res. 6, 565-570 (1972)) and as an indirect competitive binding assay for the amount of antigen in a liquid sample. (Copending application Ser. No. 851,491, filed Nov. 14, 1977 in the name of Oliveira et al and assigned to the same assignee as the present invention.) What is surprising about this invention is the discovery that after a primary layer of antibody has bound specifically to an antigen adsorbed on a crystal oscillator, a second layer of antibody specific reagent can be bound to the primary layer for purposes of assaying the primary layer both qualitatively and quantitatively.
    Piezoelectric oscillators are commonly used in electronic equipment or clocks as frequency standards and controllers. Generally, they consist of a small quartz wafer (or other material), having metal electrodes deposited on either side and some means provided for making electrical contact with an oscillator circuit. When placed in such a circuit, the portion of the wafer located between the electrodes vibrates with the precise natural frequency of the wafer. A given mass coupled to the electrode of the oscillator or crystal (used interchangeably herein) causes a decrease in the initial frequency of the crystal in an amount proportional to the mass added. Shons et al supra describe a direct method for measuring the amount of an antibody in a liquid sample using a piezoelectric quartz crystal. The crystal is first coated with the antigen specific for the antibody being assayed and its frequency measured. The coated crystal is then exposed to the sample containing the antibody. The change in frequency of the crystal due to antibody pickup is a direct measurement of the amount of total antibody in the sample.
    An indirect method for determining the amount of an antigen in a liquid sample is disclosed by Oliveira et al supra. Piezoelectric oscillator having an antigen adsorbed on the surface thereof is exposed to a sample containing the antigen, and a predetermined amount of antibody specific for the antigen. The antigen attached to the crystal competes with the antigen in the sample for the supply of antibody. The change in frequency of the piezoelectric oscillator is compared to a reference curve, and the amount of antigen in the sample is indirectly determined.
    The present invention goes beyond the assays described by Oliveria et al and Shons et al and provides a method for identifying which class of antibody has been picked up by the antigen-precoated piezoelectric oscillator.
    Thus, the basis for the present invention is the employment of a piezoelectric oscillator in such a manner that after an antigen has been bound to the oscillator surface and the oscillator reacted with an antiserum to determine the total antigen-specific antibody content of that antiserum, one then applies a second layer of reactive material to the oscillator. This reactive material or "sandwiching" layer is specifically reactive with the class or subclass of antibody that was first bound to the antigen on the oscillator surface. This second or sandwiching layer has specificity for the type of antibody to be quantitated. The class of antibody bound to the antigen is determined by the specificity of the sandwiching layer toward a particular antibody class or subclass. The amount of that antibody class or subclass is determined by comparison with a standard curve.
    According to the present invention there is provided a quantitative method for determining classes of antigen-specific antibodies comprising the steps of (1) contacting a liquid sample suspected of containing a preselected antibody with the surface of a piezoelectric oscillator having a layer of a antigen adsorbed thereon for which said antibody is specific; (2) washing and drying said oscillator; (3) measuring the frequency of said oscillator; (4) contacting said oscillator with liquid reagent containing a predetermined amount of a material reactive with a particular class of said antibody; (5) washing and drying said oscillator, and (6) measuring the change in resonance frequency (Hz) of said oscillator from said previous measurement.
    The procedure for preparing the oscillators by adsorbing the antigen thereon prior to the initial step of the above-described method is described in copending application Ser. No. 851,491, filed Nov. 14, 1977, which disclosure is incorporated herein by reference.
    Basically, the antigen may be attached to the oscillator by a number of conventional techniques known in the art for attaching proteins to solid supports. The antigen may simply be allowed to adsorb from an aqueous solution onto the surface of the oscillator. This method is least preferred because it results in a relatively high degree of nonspecific adsorption during the assay, and sensitivity is reduced.
    Another technique for depositing the antigen on the oscillator is by crosslinking the protein antigen with a conventional agent such as glutaraldehyde.
    Antigens may also be bound to the oscillator by first applying a priming coat. Antigens may be deposited on hydrophobic polymer-coated oscillators (such as polystyrene or fluorinated polymers) in which case attachment occurs by dispersion force interaction. One disadvantage with this method is that it may lead to nonspecific adsorption when the surface is exposed to additional proteins, for example, during the assay.
    Similarly, priming materials such as gum arabic which binds proteins through anionic interactions may be used.
    An especially preferred class of priming agents for the attachment of the antigen to the oscillator is described in copending application Ser. No. 851,492, filed Nov. 14, 1977, assigned to the assignee of the present application and also incorporated herein by reference. These priming agents are polymers, preferably poly(2-hydroxy-3-dimethylamino-1,4-butane) which when applied to the surface of the oscillator promote the deposition of a uniform layer of antigen on the oscillator. Nonspecific adsorption during the assay is minimized and a high degree of sensitivity is achieved.
    The antigen is immobilized or adsorbed on the oscillator (treated or untreated) by exposing the oscillator to an aqueous solution of the antigen. A simple antigen may be present in the solution or the antigen may consist of a complex mixture of molecules. Optimum concentration for attachment (or adsorption) varies from antigen to antigen according to their solubility or molecular weight, however, concentrations in the range of 0.1 to 100 milligrams per milliliter are generally preferred. Attachment is accomplished preferably at room temperature and at a pH which maintains the biological activity of the antigen. Optimum time for the attachment of antigens to the oscillator varies with the molecular weight and polarity of the antigen.
    Before removing the oscillator from the antigen solution, a water wash is directed into the solution and the oscillator is thoroughly washed without contacting the air. This wash procedure prevents contact of the oscillator with denatured protein at an air-protein solution interface. The oscillator is removed and allowed to dry. The frequency of the coated oscillator is then determined. The oscillator is ready to be used in an immunochemical assay.
    The antigen-coated oscillator is stable and may be stored for extended periods of time (e.g. several months) without loss of immunological activity.
    To assay for the amount of antigen-specific antibody in a solution, the solution is applied to the antigen-coated crystal surface. This may be accomplished either by immersion of the crystal in the antibody solution or by application of the antibody solution to a single side of a crystal. If a single side of an oscillator is used the other side may be separately employed for a subsequent assay. This solution optimally contains antibody to the specific antigen in concentrations of 0.1 to 100 ug/ml. The crystal may be incubated at temperatures preferably between 4° and 37° C. and for a period preferably ranging from 15 minutes to 24 hours.
    After the oscillator is washed and dried, its resonance frequency is measured. If one desires to quantify the amount of total antibody picked up by the oscillator, it is also necessary to measure the resonance frequency of the oscillator immediately prior to contacting the oscillator with the antibody solution and compare to a standard cure.
    To perform an assay for the determination and/or quantitation of the particular type of antibody bound in the first reaction, a solution of material specific for a select type of antibody is applied to the crystal surface in the manner and under the circumstances described above for the assay of the total amount of antigen-specific antibody. In this case the material used to characterize an antibody may be any material that binds specifically to a particular species, class or subclass of antibody. Such materials include anti-antibodies, Protein A, Staphlococcus aureus and certain lectins. Such materials must be presented to the crystal at a concentration that is in excess of that which can be bound by a crystal saturated with the first antibody.
    After incubation with this antibody-specific material the oscillator is washed and dried and its resonance frequency is measured. From this reading and the past frequency a change in reading due to the added mass of the newly attached antibody-specific material is calculated. This resultant change in resonance frequency (Hz) may be interpreted in any of a number of ways. Firstly, it may be taken as a qualitative indication that the antibody bound in the primary assay was of a specific type. Secondly, by comparison to assays run with predetermined amounts of a given type of antigen specific antibody, the actual amount of antibody bound may be ascertained in ug/ml. Depending on the manner of the definition of this standardized reagent, the primary layer of antigen specific antibody may be quantitated in either units of ug/ml, IU/ml or reciprocals of dilution, i.e., titer. Alternatively, this procedure may be employed to yield data that is of value entirely on the basis of comparison of one test sample with another.
    A convenient means for carrying out the method of the invention is to provide an immunological diagnostic kit comprising a piezoelectric oscillator having an antigen adsorbed thereon. In conjunction with the antigen oscillator composite there is provided a reagent containing a predetermined amount of a reagent specifically reactive with a particular class of antibody. A sample of patient serum is contacted with the oscillator. The change in frequency of the oscillator is optionally measured at this point if total antibody pick up is to be determined. After washing and drying of the oscillator, it is then contacted with the reagent containing the sandwiching material. Following incubation (preferably about 75 minutes) the oscillator is washed, dried, and its resonance frequency measured.
    The change in frequency due to the attachment of the sandwiching material is directly proportional to the amount of the specific class of antibody in the serum sample.
    Classes of antibodies to virtually all antigenic materials of clinical interest may be determined using the present invention. Those of particular interest include antibodies to allergens such as honey bee venom; antibodies to viral antigens; antibodies to autoantigens, i.e., to nucleic acids, to gamma globulins, to hormones or to tissue specific antigens; antibodies specific to bacterial antigens or bacterial products such as toxins and antibodies to fungal or parasitic antigens or products of these organisms.
    
    
    The invention may be further described by the following non-limiting examples.
    The procedure followed for this sandwich assay begins with the cleaning of the quartz crystal oscillators. The crystals are cleaned either by immersion in a 10% aqueous solution of trisodium phosphate for 1 hour at 20° C. with subsequent rinsing in distilled water or by immersion in trichloroethylene for 30 seconds followed by 5 consecutive rinses of 5 seconds each in distilled water then immersion in an ultrasonic bath containing 190 proof ethanol for 15 to 45 minutes and drying under a stream of dry nitrogen gas. The crystals were then treated with the primer poly(2-hydroxy-3-dimethylamino-1,4 butane) (DIMA) by immersion in an 0.08% aqueous solution thereof for 18 hours at 20° C. Following rinsing with distilled water, the crystals were dried. Subsequently these quartz crystal oscillators were immersed in a solution of honey bee venom (HBV, Sigma Chemical Company, St. Louis, Missouri) at a concentration of 10 mg/ml in 0.02 M phosphate buffer, pH 7.0. Adsorption of the HBV occurred during a four hour incubation at 20° C. The crystals were then rinsed with distilled water, dried and their resonance frequency measured. The assay was performed by applying 50 μl aliquots of a dilution of serum of a patient who had been undergoing desensitization therapy employing injections of honey bee venom. The serum was applied to one side of a crystal held in a horizontal position. The crystals and serum were incubated for 75 minutes at 20° C. The crystals were rinsed, dried and the resonance frequency measured.
    To determine the amount of IgG of antibody bound to the honey bee venom, a second layer of antibody specific for human IgG class antibody was applied to the crystal surface. This reagent was goat anti-human IgG (Meloy Laboratories, Inc., Springfield, Virginia) applied at a concentration of 50 g/ml in 0.02 M phosphate buffered saline, pH 7.0. This was applied in a 50 μl drop to the surface of a horizontal crystal. The crystals covered with this reagent were then incubated at 20° C. for 75 minutes, rinsed, dried and their resonance frequencies noted. To determine the relative amount of anti-HBV of the IgE class that was in the serum sample, the same procedure was followed as described for IgG determination except the sandwiching layer was Sheep anti-human IgE (Pharmacia AB, Uppsala Sweden).
    This same serum sample was also assayed via an RIA method to determine the concentration of IgG anti-phospholipase A antibody in μg/ml. (Phospholipase A is the major allergenic component of honey bee venon.) The results of these assays are tabulated below in Table I. The change in frequency of the quartz oscillator is referred to as Hz. Shown are the Hz frequency shifts from both the primary assay for total anti-HBV antiserum and from the secondary assay for either human IgG or human IgE class antibodies as determined by the sandwich assay. These results demonstrate that the sandwich assay method yields results in basic agreement with a convention RIA methodology.
                  TABLE I                                                     
______________________________________                                    
Titer   Hz-Total  ΔHz of Anti                                       
                               ΔHz of Anti                          
(μg/ml)                                                                
        Antibody  IgG vs.      IgE vs.                                    
by RIA  vs. HBV   Total Antibody                                          
                               Total Antibody                             
______________________________________                                    
46.5    454.0     223.0        --                                         
23.25   395.0     182.0        93.5                                       
11.6    305.0     158.0        57.0                                       
5.8     149.0     163.0        47.0                                       
2.9     76.0      99.0         --                                         
______________________________________                                    
    
    A second assay was performed using nine different sera samples from patients who had been desensitized to honey bee venom. It was expected that these patients would have high levels of IgG antibody to the injected allergens. This assay was performed in the manner and with the reagents described in Example 1. However, in this instance, the antigen adsorbed onto the crystal surface was phospholipase A (PLA) (Sigma Chemical Company, St. Louis, Mo.). The PLA was applied as a 50 μl drop to a single side of a horizontal crystal one side at a time at a concentration of 5 mg/ml in 0.02 M phosphate buffer, pH 7.0.
    In order to demonstrate the usefulness of this technique for determination of the actual concentration of antiPLA IgG class antibody in μg/ml the ΔHz resulting from the assay of these sera were compared with a standard curve. The standard curve was derived from an assay of aliquots of dilutions of serum having known concentration of the IgG antibody. The equation for the linear portion from 157 ΔHz to 283 ΔHz of this curve was derived and used in calculating the concentration of PLA specific IgG in the nine unknown samples. This equation is y=bx+m where y=ΔHz, b=the slope, m=y intercept and x=the antibody concentration in μg/ml. In this case b=10.78 and m=148.5. Because varying dilutions of these sera were employed the calculated titer from this assay equals X times the dilution factor. The following Table 2 sets forth the results of this assay and the values of IgG class anti PLA derived from RIA for purposes of comparison. The points on the curve were plotted using the following values:
    ______________________________________ Titer (μg/ml) ΔHz ______________________________________ 25.50 283.0 12.75 218.0 6.38 177.0 3.19 157.0 ______________________________________
              TABLE 2                                                     
______________________________________                                    
      ΔHz                Calculated                                 
                                        RIA                               
Sera  Anti-IgG  Dilution  X    μg/ml μg/ml                          
______________________________________                                    
1     117.5     1:4       4.2  16.8     11.7                              
2     144.5     1:4       19.3 77.1     94.0                              
3     164.0     1:4       30.2 120.1    136.0                             
4     184.0     1:1       41.5 41.5     40.8                              
5     210.0     1:4       56.3 225.3    292.0                             
6     137.0     1:4       15.1 60.0     73.6                              
7     192.8     1:1       46.3 46.3     54.6                              
8     159.8     1:8       27.8 222.6    225.0                             
9     134.0     1:4       13.7 13.7     18.2                              
______________________________________                                    
    
    This example illustrates that the sandwich assay yields useful data in terms of actual concentration of antibody in units such as μg/ml. The method can be employed for useful clinical purposes such as monitoring the efficacy of desensitization therapy. The method is equally applicable to assays of antibodies that may be directed against a single antigen or to a mixture of antigens (cf. Example 1).
    This example illustrates the efficacy of the sandwich technique in the quantitation of different classes of specific antibodies to keyhole limpet hemocyanin in the same serum.
    Antiserum was raised in rabbits to the antigen keyhole limpet hemocyanin (KLH, Lot. No. 730192, A. grade, Calbiochem-Behring Corp., San Diego, Calif.) by injecting the animals with 4 mg of alum (Al(OH)3) precipitated KLH in 1 ml of saline intravenously. The rabbits were bled 3 days post injection and serum was collected. To assay for different classes of specific antibodies to KLH with the quartz crystal oscillators, the standard procedure was used (see example 1) except for the following modifications. KLH in solution (5 mg/ml) was incubated on the crystals for 24 hours instead of 4 hours. Incubations of antisera on the crystals were carried out for 3 hours instead of 75 minutes. The antiserum used was rabbit anti-KLH and the sandwiching material was sheep anti-rabbit IgG, Fc fragment, heavy chain specific, and sheep anti-rabbit IgM, heavy chain specific (Cappel Laboratories, Inc. Cochranville, Pa.). The anti-rabbit IgG used was diluted 1/10 in 0.02 M phosphate buffered saline, pH 7.0, and the anti-rabbit IgM was undiluted. Anti-rabbit IgG and anti-rabbit IgM had been shown by immuno-electrophoresis and immunodiffusion to be monospecific. The following results were obtained.
                  TABLE 3                                                     
______________________________________                                    
Dilution of Hz post    Hz post    Hz post                                 
Anti-KLH    anti-KLH.sup.2                                                
                       anti-IgG.sup.3                                     
                                  anti-IgM.sup.3                          
______________________________________                                    
1/5         557        504        358                                     
1/10        424        447        325                                     
1/20        298        464        314                                     
1/40        138        397        208                                     
1/80        45         339        148                                     
______________________________________                                    
 .sup.1 Values given are the averages of duplicate                        
 .sup.2 Values given are half the values obtained from crystals with both 
 sides reacted with antiKLH-                                              
 .sup.3 Values given are obtained from crystals with only one side reacted
 with either antirabbit IgG or antirabbit IgM.                            
    
    As shown by the results in Table 3, relative amounts of IgG and IgM antibodies to KLH can be measured in the same serum. Therefore, by the use of monospecific antibodies to different classes of immunoglobulin, one can quantitate the relative amounts of different classes of antigen specific antibodies in the same serum without necessitating prior separation of the classes of antibodies.
    This example illustrates the species-specific binding affinity of anti-human IgG for human IgG in the sandwich assay.
    Honey bee venom (HBV) was used as the test antigen (see example 1). Human serum with a high titer of anti-HBV activity was reacted with the crystals having HBV adsorbed thereon. Goat anti-human IgG (A102, 89373, 3.9 mg antibody/ml, Meloy Laboratories Inc., Springfield, Va.) and sheep anti-rabbit IgG were used undiluted as sandwiching layers. The following results were obtained.
                  TABLE 4                                                     
______________________________________                                    
Antiserum            ΔHz                                            
______________________________________                                    
Goat Anti-human IgG  278                                                  
Sheep anti-rabbit IgG                                                     
                     no mass added                                        
______________________________________                                    
    
    Therefore, when the crystals have human anti-HBV IgG on them, only goat anti-human IgG was able to bind to the crystals. It is concluded from this that the sandwich technique can be used to determine the specific species of the first layer of antibody by the use of an appropriate second layer of anti-antibody.
    This example illustrates that when a given class or species of antibody is not detected by the corresponding anti-antibody, the same surface of the crystal can be used to assay for a different class or species of antibody by the sandwich assay.
    Crystals having KLH adsorbed thereon to which was bound a layer of rabbit anti-KLH were incubated with sheep anti-rabbit IgM diluted 1/20. When no binding of the anti-IgM was measured, the same surface of the crystals were incubated with sheep anti-rabbit IgG diluted 1/20. The following results were obtained.
    TABLE 5 ______________________________________ Antiserum ΔHz ______________________________________ Anti-rabbit IgM no mass added Anti-rabbit IgG 106 ______________________________________
Therefore, when the sandwich assay has been performed to determine if a given class or species of antibody has bound to an antigen on a crystal surface and the results are negative, this procedure may be repeated on the same crystal surface using a secondary anti-antibody to a different class or species of antibody.
    This example illustrates the use of the sandwich assay with anti-viral antibodies against viral antigens.
    In order to demonstrate the applicability of this assay method to other types of antigens, the sandwich assay was applied to rabbit anti-Rubella antibodies that had reacted with Rubella virus antigens adsorbed onto quartz crystals. This assay was performed according to the method of example 1. In this case the antigens were either Rubella hemagglutination antigen or Rubella complement fixation antigen, or the appropriate controls. These are all products of Flow Laboratories, Inc. of Rockville, Maryland, and were used without modification. The first layer antisera used was either Rubella neutralizing rabbit antiserum or rabbit preserum, also from Flow Laboratories. The second layer antiserum used was sheep anti-rabbit IgG from Cappel Laboratories, Cochranville, Pa. The results are shown in Table 6.
                  TABLE 6                                                     
______________________________________                                    
                       ΔHz of                                       
                                  ΔHz of                            
                       RABBIT     Anti                                    
ANTIGEN    ANTISERUM   ANTIBODY   Rabbit IgG                              
______________________________________                                    
Hemagglutination                                                          
           Neutralizing                                                   
                       64         191                                     
Hemagglutination                                                          
           preserum    27         78                                      
Hemagglutination                                                          
           Neutralizing                                                   
                       1          82                                      
control                                                                   
Complement Neutralizing                                                   
                       40         221                                     
fixation                                                                  
Complement Preserum    No Mass    72                                      
fixation               Added                                              
Complement Neutralizing                                                   
                       19         104                                     
fixation control                                                          
______________________________________                                    
    
    These data indicate that the sandwich assay is applicable to the characterization of antibodies directed against various types of viral antigens. The parallelism between the primary and secondary (sandwich antibody) layers points to the usefulness of this technique in characterizing anti-viral antibodies and in serving as an amplification of the initial antigen-antibody reaction.
    In view of the ability to assay antibodies against a viral antigen and the ability of this procedure to quantitate the relative amounts of each class of antibody, the present invention can be used to assay for the class of anti-Rubella virus antibody present in a patient's serum. This is useful in diagnosing the occurance of Rubella infections in pregnant women.
    This example illustrates the use of an appropriate secondary layer other than an immunoglobulin to obtain information regarding the first layer of antibodies in the sandwich assay.
    Protein A synthesized by the bacteria Staphylococcus aureus has been shown to bind the Fc region of IgG from several species of animals. Protein A, (Sigma Chemical Co., St. Louis, Mo.) at a concentration of 5 mg/ml in 0.2 M phosphate buffered saline, pH 7.0, was incubated with crystals that had varying amounts of rabbit anti-KLH bound to the KLH on their surfaces. The following results were obtained.
                  TABLE 7                                                     
______________________________________                                    
Dilution of    ΔHz post                                             
                           ΔHz post                                 
anti-KLH       anti-KLH    Protein A                                      
______________________________________                                    
1/10           437         216                                            
1/20           368         202                                            
1/40           301         183                                            
1/80           176         114                                            
______________________________________                                    
    
    Protein A is therefore capable of binding specifically to the rabbit IgG anti-KLH on the crystals. Thus, it is possible to use other biospecific molecules that will bind to the first layer of antibodies in the sandwich assay.
    This example illustrates the use of bacterial cells with specific surface receptors as a second sandwich layer.
    Cells with receptors on their surface specific for a particular type of antibody can also be used as a sandwich layer. This layer may serve for either a qualitative or quantitative analysis of the amount and/or type of antibody bound to an antigen. In this example the crystals were prepared and assayed as described in Example 1. The antigen was bovine serum albumin (BSA). (Sigma Chemical Co., St. Louis, Mo. at 10 mg/ml in phosphate buffer pH 7.0). The primary anti-serum was Rabbit anti-BSA. The second or sandwich layer was a 10% suspension of Staphlococcus aureus, Cowan I, ATCC 12578, grown up in CCYI media, killed, washed and suspended in PBS. This preparation was incubated on a crystal for 75 minutes at 20° C. Table 8 gives the results of this experiment.
                  TABLE 8                                                     
______________________________________                                    
ΔHz with Rabbit                                                     
                  ΔHz with 10%                                      
anti-BSA          Staphlococcus Aureus                                    
______________________________________                                    
604               242                                                     
PBS               No Mass Added                                           
______________________________________                                    
    
    In this case these cells have protein A on their surface. This is a molecule that binds specifically to the Fc portion of the IgG antibodies of several species.
    This example illustrates priming of the quartz crystals with polystyrene prior to deposition of the antigen coat. Proteins bind to polystyrene through dispersion forces. To demonstrate this, crystals were dipped in 1.5% polystyrene in toluene, dried with nitrogen and kept at room temperature for 24 hours to allow residual toluene to evaporate. Phospholipase A (PLA, Sigma Chemical Co. St. Louis, Mo.) an antigenic component of honey bee venon was applied at 5 mg/ml in 0.02 M phosphate buffer pH 70. The assay was performed as described in Example 1 using as the antibody source the same type of human sera samples and antihuman IgG (Meloy, Springfield, Va.) at 50 μg/ml in 0.02 M phosphate buffered saline pH 7.0.) The frequency change (ΔHz) shown in Table 9 is a quantitation of phospholipase A specific-antibody of the IgG class.
                  TABLE 9                                                     
______________________________________                                    
                     ΔHz total                                      
                                ΔHz anti                            
         Titer (μg/ml)                                                 
                     antibody   IgG vs. total                             
Sera #   by RIA.sup.1                                                     
                     vs. PLA    antibody                                  
______________________________________                                    
1        3.5         91.5       93.5                                      
2        31.0        106.0      160.0                                     
3        41.0        149.5      184.5                                     
4        51.0        160.5      183.0                                     
______________________________________                                    
 .sup.1 RIA (radioimmuno assay).                                          
    
    The data presented in Table 9 illustrate that antigen specific IgG quantitation using the sandwich assay correlates with RIA titers using polystyrene primed crystals.
    This example illustrates that an antigen can be bound to a quartz crystal by chemical crosslinking. As an illustration, glutaraldehyde was used to crosslink the antigen. The following mixture was painted on a cleaned crystal:
    100 μl of acetate buffer pH 5.0
    200 μl of the antigen, phospholipase A at 10 mg/ml in 0.02 M phosphate buffer pH 7.0
    50 μl of 25% glutaraldehyde in water.
    To facilitate crosslinking of the antigen, the crystals were incubated at room temperature in a moist environment for 16 hours, and rinsed by immersion into distilled water 3 times for 1 hour. A non-antigenic protein was applied to react with free glutaraldehyde remaining on the crystal. To this purpose, bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.) was applied at 10 mg/ml in 0.02 M phosphate buffer, pH 7.0.
    The antibody assays were performed using the method described in Example 1 and the materials described in Example 9.
                  TABLE 10                                                    
______________________________________                                    
                     ΔHz total                                      
                                ΔHz anti                            
        Titer (μg/ml)                                                  
                     antibody   IgG vs. total                             
Sera    by RIA       vs. PLA    antibody                                  
______________________________________                                    
1       3.5          77.5       29.5                                      
2       6.5          32.5       87.0                                      
3       41.0         77.5       135.5                                     
4       57.0         59.0       156.0                                     
______________________________________                                    
    
    The data presented in Table 10 illustrate that the sandwich assay can be carried out using crosslinked antigen. Although the total antibody binding (ΔHz) to phospholipase A appears to be non-specific, the sandwich assay data (ΔHz of anti-IgG) correlated well with RIA titers.
    This example illustrates the use of gum arabic to attach the antigen to the crystal through anionic. interactions. Gum arabic (Sigma Chemical Co., St. Louis, Mo.) was applied to a crystal at 10 mg/ml in 0.02 M phosphate buffer, pH 7.2. The methodology and materials used in this assay are described in Examples 1 and 9, respectively.
    The data presented in Table 11 illustrate that the sandwich assay can be used to characterize primary antibody layers that have bound to the antigen attached to gum arabic-primed crystals.
                  TABLE 11                                                    
______________________________________                                    
                    ΔHz total                                       
                                 ΔHz anti                           
        Titer (μg/ml)                                                  
                    antibody     IgG vs. total                            
Sera    by RIA      vs. PLA      antibody                                 
______________________________________                                    
1       0.          No Mass Added                                         
                                 10.0                                     
2       4.8         108.0        168.0                                    
3       10.25       111.5        184.0                                    
4       12.75       115.0        223.0                                    
______________________________________                                    
    
    
  Claims (19)
1. A quantitative method for determining at least one class of antigen-specific antibodies comprising the steps of:
    (1) contacting a liquid sample suspected of containing an antibody with the surface of a piezoelectric oscillator having a layer of antigen for which said antibody is specific adsorbed thereon;
 (2) washing and drying said oscillator;
 (3) measuring the resonance frequency of said oscillator;
 (4) contacting said surface of said oscillator with a liquid reagent containing a predetermined amount of a material reactive with a particular class of said antibody;
 (5) washing and drying said oscillator; and
 (6) measuring the change in resonance frequency of said oscillator from said first measurement.
 2. The method according to claim 1 wherein said reactive material is an anti-antibody.
    3. The method of claim 2 wherein said anti-antibody is selected from the group consisting of anti-IgG, anti-IgM, anti-IgE, anti-IgA and anti-IgD.
    4. The method according to claim 1 wherein said reactive material is Protein A.
    5. The method according to claim 1 wherein said reactive material is antibody class specific receptors or cells having said receptor on the surface thereof.
    6. The method according to claim 1 wherein said oscillator is a quartz crystal.
    7. The method according to claim 6 wherein said oscillator has adsorbed thereon a monolayer poly(2-hydroxy-3-dimethylamino-1,4-butane) to which is attached said antigen layer.
    8. The method according to claim 6 wherein said oscillator has adsorbed thereon a layer of polystyrene to which is attached said antigen.
    9. The method according to claim 6 wherein said antigen is chemically crosslinked on said oscillator.
    10. The method according to claim 1 wherein said antigen is an allergen.
    11. The method according to claim 1 wherein said antigen is selected from the group consisting of viral, bacterial, fungal and parasitic antigens.
    12. A diagnostic test kit for the quantitative determination of at least one class of antigen-specific antibodies comprising:
    a piezoelectric oscillator having a layer of antigen for which said antibody is specific adsorbed thereon; and
 a reagent containing a predetermined amount of a material reactive with a particular class of said antibody.
 13. The kit according to claim 12 wherein said reactive material is an anti-antibody.
    14. The kit according to claim 13 wherein said anti-antibody is selected from the group consisting of anti-IgG, anti-IgE, anti-IgM, anti-IgA and anti-IgD.
    15. The kit according to claim 12 wherein said reactive material is Protein A.
    16. The kit according to claim 12 wherein said reactive material is antibody class specific receptors or cells having said receptor on the surface thereof.
    17. The kit according to claim 12 wherein said oscillator is a quartz crystal.
    18. The kit according to claim 12 further comprising at least one reference antibody preparation containing a known amount of a specific class of antibody.
    19. The kit according to claim 12 wherein said oscillator has adsorbed thereon a monolayer of poly(2-hydroxy-3-dimethylamino-1,4-butane) to which is attached said antigen layer.
    Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US06/028,348 US4236893A (en) | 1979-04-09 | 1979-04-09 | Method for the assay of classes of antigen-specific antibodies | 
| CA348,371A CA1131341A (en) | 1979-04-09 | 1980-03-25 | Method for the assay of classes of antigen specific antibodies | 
| PCT/US1980/000314 WO1980002201A1 (en) | 1979-04-09 | 1980-03-31 | Method for the assay of classes of antigen-specific antibodies | 
| AU59934/80A AU538366B2 (en) | 1979-04-09 | 1980-03-31 | Method for the assay of classes of antigen-specific antibodies | 
| DE8080900749T DE3070944D1 (en) | 1979-04-09 | 1980-03-31 | Method for the assay of classes of antigen-specific antibodies | 
| US06/172,755 US4314821A (en) | 1979-04-09 | 1980-07-28 | Sandwich immunoassay using piezoelectric oscillator | 
| EP80900749A EP0026215B1 (en) | 1979-04-09 | 1980-10-23 | Method for the assay of classes of antigen-specific antibodies | 
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US06/028,348 US4236893A (en) | 1979-04-09 | 1979-04-09 | Method for the assay of classes of antigen-specific antibodies | 
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| US06/172,755 Continuation-In-Part US4314821A (en) | 1979-04-09 | 1980-07-28 | Sandwich immunoassay using piezoelectric oscillator | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| US4236893A true US4236893A (en) | 1980-12-02 | 
Family
ID=21842943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| US06/028,348 Expired - Lifetime US4236893A (en) | 1979-04-09 | 1979-04-09 | Method for the assay of classes of antigen-specific antibodies | 
Country Status (5)
| Country | Link | 
|---|---|
| US (1) | US4236893A (en) | 
| EP (1) | EP0026215B1 (en) | 
| CA (1) | CA1131341A (en) | 
| DE (1) | DE3070944D1 (en) | 
| WO (1) | WO1980002201A1 (en) | 
Cited By (78)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4314821A (en) * | 1979-04-09 | 1982-02-09 | Minnesota Mining And Manufacturing Company | Sandwich immunoassay using piezoelectric oscillator | 
| US4596697A (en) * | 1984-09-04 | 1986-06-24 | The United States Of America As Represented By The Secretary Of The Army | Chemical sensor matrix | 
| US4614722A (en) * | 1983-11-01 | 1986-09-30 | Pasula Mark J | Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies | 
| US4618589A (en) * | 1980-07-16 | 1986-10-21 | The University Of Birmingham | Immunoprecipitation assay of immunoglobulins using monoclonal antibodies | 
| US4689400A (en) * | 1985-06-27 | 1987-08-25 | The United States Of America As Represented By The Secretary Of The Navy | Enhancement of specific antibody production with anti-IgD antibodies | 
| US4713347A (en) * | 1985-01-14 | 1987-12-15 | Sensor Diagnostics, Inc. | Measurement of ligand/anti-ligand interactions using bulk conductance | 
| US4735906A (en) * | 1984-11-28 | 1988-04-05 | Texas A&M University | Sensor having piezoelectric crystal for microgravimetric immunoassays | 
| US4767719A (en) * | 1986-05-20 | 1988-08-30 | Amersham International Plc | Assay apparatus having piezoelectric slab generating effective diffraction grating in applied analyte-specific film | 
| US4769121A (en) * | 1987-05-01 | 1988-09-06 | Biotronic Systems Corporation | Sintered pellet with biochemically active layer | 
| US4777019A (en) * | 1985-04-12 | 1988-10-11 | Thomas Dandekar | Biosensor | 
| US4789804A (en) * | 1985-09-17 | 1988-12-06 | Seiko Instruments & Electronics Ltd. | Analytical device and method utilizing a piezoelectric crystal biosensor | 
| US4847193A (en) * | 1987-06-18 | 1989-07-11 | Gene-Trak Systems | Signal amplification in an assay employing a piezoelectric oscillator | 
| US5001053A (en) * | 1987-03-31 | 1991-03-19 | Nihon Kohden Corporation | Method and apparatus for measuring the product of an antigen-antibody reaction | 
| US5135852A (en) * | 1989-07-25 | 1992-08-04 | E. I. Du Pont De Nemours And Company | Piezoelectric cell growth biosensing method using polymer-metabolic product complex interactions | 
| US5447869A (en) * | 1987-03-11 | 1995-09-05 | Sogo Pharmaceutical Company Limited | Method of detecting bitter or odorous substances and apparatus therefor | 
| US5447845A (en) * | 1993-06-01 | 1995-09-05 | E. I. Du Pont De Nemours And Company | Analyte-responsive KTP composition and method | 
| US5455475A (en) * | 1993-11-01 | 1995-10-03 | Marquette University | Piezoelectric resonant sensor using the acoustoelectric effect | 
| US5478756A (en) * | 1990-07-24 | 1995-12-26 | Fisons Plc | Chemical sensor for detecting binding reactions | 
| US5494639A (en) * | 1993-01-13 | 1996-02-27 | Behringwerke Aktiengesellschaft | Biosensor for measuring changes in viscosity and/or density of a fluid | 
| EP0737853A1 (en) * | 1995-04-10 | 1996-10-16 | BEHRINGWERKE Aktiengesellschaft | Biosensor | 
| US5595908A (en) * | 1985-09-26 | 1997-01-21 | University Of Southern Mississipi | Piezoelectric device for detection of polynucleotide hybridization | 
| EP0781999A1 (en) | 1995-12-27 | 1997-07-02 | Behringwerke Ag | Mass-sensitive biosensors | 
| US5658732A (en) * | 1989-10-04 | 1997-08-19 | E. I. Du Pont De Nemours And Company | Assay method for biological target complexes on the surface of a biosensor | 
| US5728583A (en) * | 1993-11-11 | 1998-03-17 | Jeol, Ltd. | Determination of abnormal part of blood functions | 
| US5814525A (en) * | 1996-01-25 | 1998-09-29 | Sandia Corporation | Piezoelectric biosensor with a ladder polymer substrate coating | 
| US5843682A (en) * | 1995-11-20 | 1998-12-01 | Boehringer Mannheim Corporation | N-1-carboxyalkyl derivatives of LSD | 
| US5932953A (en) * | 1997-06-30 | 1999-08-03 | Iowa State University Research Foundation, Inc. | Method and system for detecting material using piezoelectric resonators | 
| US6010866A (en) * | 1990-04-27 | 2000-01-04 | Genzyme Corporation | Determination of analytes in biological fluids in the presence of substances interfering with assays therefor | 
| US6016686A (en) * | 1998-03-16 | 2000-01-25 | Lockheed Martin Energy Research Corporation | Micromechanical potentiometric sensors | 
| US6033852A (en) * | 1996-09-27 | 2000-03-07 | University Of Maine | Monolithic piezoelectric sensor (MPS) for sensing chemical, biochemical and physical measurands | 
| RU2148259C1 (en) * | 1998-04-17 | 2000-04-27 | Ставропольский научно-исследовательский противочумный институт | Method for detecting macromolecules using biosensory device | 
| US6118124A (en) * | 1996-01-18 | 2000-09-12 | Lockheed Martin Energy Research Corporation | Electromagnetic and nuclear radiation detector using micromechanical sensors | 
| US6167748B1 (en) | 1998-08-31 | 2001-01-02 | Lockheed Martin Energy Research Corporation | Capacitively readout multi-element sensor array with common-mode cancellation | 
| US6207396B1 (en) | 1995-11-20 | 2001-03-27 | Microgenics Corporation | Immunoassay reagents and methods for determination of LSD and LSD metabolites | 
| US6289286B1 (en) * | 1998-05-29 | 2001-09-11 | Biacore Ab | Surface regeneration of biosensors and characterization of biomolecules associated therewith | 
| US6289717B1 (en) | 1999-03-30 | 2001-09-18 | U. T. Battelle, Llc | Micromechanical antibody sensor | 
| US20020102743A1 (en) * | 1999-08-19 | 2002-08-01 | The Regents Of The University Of California | Apparatus and method for visually identifying micro-forces with a palette of cantilever array blocks | 
| US20030154149A1 (en) * | 2002-02-13 | 2003-08-14 | Dilip Gajendragadkar | System and method of creating and executing a restricted stock sale plan | 
| US6630309B2 (en) | 1995-07-21 | 2003-10-07 | Biosensor Applications Sweden Ab | Determination of an analyte in a liquid medium | 
| US20030194697A1 (en) * | 1999-04-22 | 2003-10-16 | David Klenerman | Measurement and use of molecular interactions | 
| US20030229211A1 (en) * | 1988-06-23 | 2003-12-11 | Wainwright Norman R. | Endotoxin binding and neutralizing protein and uses thereof | 
| US6723524B1 (en) * | 1997-12-01 | 2004-04-20 | Nederlandse Organisatie Voor Toegepastnatuurwetenschappelijk Onderzoek Tno | Immunoassay method and kit | 
| US20050003560A1 (en) * | 2003-06-05 | 2005-01-06 | Oakland Univesity | Piezoimmunosensor | 
| US20050063882A1 (en) * | 2003-09-16 | 2005-03-24 | Steris Inc. | Sensor for determining concentration of fluid sterilant | 
| US20050124896A1 (en) * | 2003-08-25 | 2005-06-09 | Jacob Richter | Method for protecting implantable sensors and protected implantable sensors | 
| US20050252274A1 (en) * | 2004-05-12 | 2005-11-17 | Steris Inc. | Method and apparatus for determining the efficiency of a vaporizer in a decontamination system | 
| US20060073077A1 (en) * | 2004-09-24 | 2006-04-06 | Steris, Inc. | Method and apparatus for determining the concentration of chemical components in a liquid or gaseous system using multiple sensors | 
| US20060105466A1 (en) * | 2004-11-12 | 2006-05-18 | Steris Inc. | Sensor for determining concentration of ozone | 
| US7135295B1 (en) | 1999-01-25 | 2006-11-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Detection of small molecules by use of a piezoelectric sensor | 
| US20070068222A1 (en) * | 2005-09-26 | 2007-03-29 | Oakland University | Ionic liquid high temperature gas sensors | 
| US20070218534A1 (en) * | 1999-04-22 | 2007-09-20 | David Klenerman | Measurement and use of molecular interactions | 
| US20080063574A1 (en) * | 2004-05-25 | 2008-03-13 | Steris Corporation | Apparatus for controlling the concentration of a sterilant chemical in a fluid | 
| US20080193965A1 (en) * | 2006-10-10 | 2008-08-14 | Oakland University | Microorganism detection and analysis using carbohydrate and lectin recognition | 
| US7473551B2 (en) | 2004-05-21 | 2009-01-06 | Atonomics A/S | Nano-mechanic microsensors and methods for detecting target analytes | 
| US20090280509A1 (en) * | 2008-05-08 | 2009-11-12 | Samsung Electronics Co., Ltd. | Surface acoustic wave immunosensor for diagnosing allergy disease and method for diagnosing allergy disease using the same | 
| US20090293590A1 (en) * | 2006-03-30 | 2009-12-03 | Oakland University | Ionic liquid thin layer sensor for electrochemical and/or piezoelectric measurements | 
| US20100238035A1 (en) * | 2009-03-19 | 2010-09-23 | Tangidyne Corporation | Detection device and method for detecting analyte | 
| US7886577B2 (en) | 2006-03-30 | 2011-02-15 | Oakland University | Devices with surface bound ionic liquids and method of use thereof | 
| US8148170B2 (en) | 2003-06-05 | 2012-04-03 | Oakland University | Immunosensors: scFv-linker design for surface immobilization | 
| WO2012076827A1 (en) | 2010-12-10 | 2012-06-14 | Universite De Technologie De Troyes | System and method for detecting biological or chemical species involving a qcm transducer | 
| US20130203182A1 (en) * | 2010-06-03 | 2013-08-08 | Phadia Ab | Method for decision support in allergy diagnosis | 
| US9377456B1 (en) * | 2014-12-30 | 2016-06-28 | Avails Medical, Inc. | Systems and methods for detecting a substance in bodily fluid | 
| WO2017005663A1 (en) * | 2015-07-03 | 2017-01-12 | Foundation For Research And Technology Hellas | Measurement of analyte with an acoustic wave sensor | 
| US10060916B2 (en) | 2013-11-21 | 2018-08-28 | Avails Medical, Inc. | Electrical biosensor for detecting a substance in a bodily fluid, and method and system for same | 
| US10161934B2 (en) | 2011-08-26 | 2018-12-25 | Aviana Molecular Technologies, Llc | Biocoated piezoelectric biosensor platform for point-of-care diagnostic use | 
| US10174356B2 (en) | 2016-05-31 | 2019-01-08 | Avails Medical, Inc. | Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives | 
| US10254245B2 (en) | 2016-01-25 | 2019-04-09 | Avails Medical, Inc. | Devices, systems and methods for detecting viable infectious agents in a fluid sample using an electrolyte-insulator-semiconductor sensor | 
| US10876144B2 (en) | 2017-07-14 | 2020-12-29 | American Sterilizer Company | Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same | 
| US10883135B2 (en) | 2015-08-25 | 2021-01-05 | Avails Medical, Inc. | Devices, systems and methods for detecting viable infectious agents in a fluid sample | 
| US10889848B2 (en) | 2017-07-14 | 2021-01-12 | American Sterilizer Company | Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same | 
| US10900062B2 (en) | 2017-07-14 | 2021-01-26 | American Sterilizer Company | Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same | 
| US10948489B2 (en) * | 2017-07-19 | 2021-03-16 | Purdue Research Foundation | Method of detecting a substance | 
| US11385200B2 (en) | 2017-06-27 | 2022-07-12 | Avails Medical, Inc. | Apparatus, systems, and methods for determining susceptibility of microorganisms to anti-infectives | 
| CN114935647A (en) * | 2022-05-12 | 2022-08-23 | 石家庄和亚生物技术有限公司 | Method for quantitatively detecting candida albicans enolase antibody | 
| US11655494B2 (en) | 2017-10-03 | 2023-05-23 | Avails Medical, Inc. | Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions | 
| US12352714B2 (en) | 2016-12-13 | 2025-07-08 | Avails Medical, Inc. | Devices, systems and methods to detect the presence of ß-lactam antibiotic hydrolyzing bacteria in a sample | 
| US12379373B2 (en) | 2018-12-03 | 2025-08-05 | Avails Medical, Inc. | Apparatus, systems, and methods for quantifying infectious agents | 
| US12422343B2 (en) | 2017-12-05 | 2025-09-23 | Avails Medical, Inc. | Apparatus, systems, and methods for preparing an output sample comprising a defined concentration of an infectious agent for downstream testing | 
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| GB8328520D0 (en) * | 1983-10-25 | 1983-11-23 | Serono Diagnostics Ltd | Methods of assay | 
| WO1987002066A1 (en) * | 1985-09-26 | 1987-04-09 | The University Of Southern Mississippi | Piezoelectric device for detection of polynucleotide hybridization | 
| US5082630A (en) * | 1990-04-30 | 1992-01-21 | The United States Of America As Represented By The United States Department Of Energy | Fiber optic detector for immuno-testing | 
| GB2244557A (en) * | 1990-06-01 | 1991-12-04 | Marconi Gec Ltd | Acoustic wave biosensor | 
| WO1993025910A1 (en) * | 1992-06-05 | 1993-12-23 | Pharmacia Biosensor Ab | Assay for multiple analytes with co-immobilized ligands | 
| CN101458222B (en) * | 2008-12-26 | 2011-12-21 | 江南大学 | Preparation of peanut or shrimp allergen rapid detecting sensor and applications | 
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US3720760A (en) * | 1968-09-06 | 1973-03-13 | Pharmacia Ab | Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples | 
| US3966898A (en) * | 1973-06-28 | 1976-06-29 | Pharmacia Diagnostics Ab | Method and reagent for determining immunologic materials | 
| US4092114A (en) * | 1976-10-20 | 1978-05-30 | Fisher Scientific Company | Indirect latex test for determination of immunoglobulins | 
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4054646A (en) * | 1973-07-30 | 1977-10-18 | General Electric | Method and apparatus for detection of antibodies and antigens | 
| US4210722A (en) * | 1977-11-14 | 1980-07-01 | Minnesota Mining And Manufacturing Company | Protein immobilizer | 
- 
        1979
        
- 1979-04-09 US US06/028,348 patent/US4236893A/en not_active Expired - Lifetime
 
 - 
        1980
        
- 1980-03-25 CA CA348,371A patent/CA1131341A/en not_active Expired
 - 1980-03-31 WO PCT/US1980/000314 patent/WO1980002201A1/en active IP Right Grant
 - 1980-03-31 DE DE8080900749T patent/DE3070944D1/en not_active Expired
 - 1980-10-23 EP EP80900749A patent/EP0026215B1/en not_active Expired
 
 
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US3720760A (en) * | 1968-09-06 | 1973-03-13 | Pharmacia Ab | Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples | 
| US3720760B1 (en) * | 1968-09-06 | 1984-02-07 | Pharmacia Ab | |
| US3966898A (en) * | 1973-06-28 | 1976-06-29 | Pharmacia Diagnostics Ab | Method and reagent for determining immunologic materials | 
| US4092114A (en) * | 1976-10-20 | 1978-05-30 | Fisher Scientific Company | Indirect latex test for determination of immunoglobulins | 
Non-Patent Citations (1)
| Title | 
|---|
| A. Shons et al., J. Biomed. Mater. Res., 6, 565-570, (1972). * | 
Cited By (106)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4314821A (en) * | 1979-04-09 | 1982-02-09 | Minnesota Mining And Manufacturing Company | Sandwich immunoassay using piezoelectric oscillator | 
| US4618589A (en) * | 1980-07-16 | 1986-10-21 | The University Of Birmingham | Immunoprecipitation assay of immunoglobulins using monoclonal antibodies | 
| US4614722A (en) * | 1983-11-01 | 1986-09-30 | Pasula Mark J | Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies | 
| US4596697A (en) * | 1984-09-04 | 1986-06-24 | The United States Of America As Represented By The Secretary Of The Army | Chemical sensor matrix | 
| US4735906A (en) * | 1984-11-28 | 1988-04-05 | Texas A&M University | Sensor having piezoelectric crystal for microgravimetric immunoassays | 
| US4713347A (en) * | 1985-01-14 | 1987-12-15 | Sensor Diagnostics, Inc. | Measurement of ligand/anti-ligand interactions using bulk conductance | 
| US4777019A (en) * | 1985-04-12 | 1988-10-11 | Thomas Dandekar | Biosensor | 
| US4689400A (en) * | 1985-06-27 | 1987-08-25 | The United States Of America As Represented By The Secretary Of The Navy | Enhancement of specific antibody production with anti-IgD antibodies | 
| US4789804A (en) * | 1985-09-17 | 1988-12-06 | Seiko Instruments & Electronics Ltd. | Analytical device and method utilizing a piezoelectric crystal biosensor | 
| US5595908A (en) * | 1985-09-26 | 1997-01-21 | University Of Southern Mississipi | Piezoelectric device for detection of polynucleotide hybridization | 
| US4767719A (en) * | 1986-05-20 | 1988-08-30 | Amersham International Plc | Assay apparatus having piezoelectric slab generating effective diffraction grating in applied analyte-specific film | 
| US5447869A (en) * | 1987-03-11 | 1995-09-05 | Sogo Pharmaceutical Company Limited | Method of detecting bitter or odorous substances and apparatus therefor | 
| US5001053A (en) * | 1987-03-31 | 1991-03-19 | Nihon Kohden Corporation | Method and apparatus for measuring the product of an antigen-antibody reaction | 
| US4769121A (en) * | 1987-05-01 | 1988-09-06 | Biotronic Systems Corporation | Sintered pellet with biochemically active layer | 
| US4847193A (en) * | 1987-06-18 | 1989-07-11 | Gene-Trak Systems | Signal amplification in an assay employing a piezoelectric oscillator | 
| US20030229211A1 (en) * | 1988-06-23 | 2003-12-11 | Wainwright Norman R. | Endotoxin binding and neutralizing protein and uses thereof | 
| US5135852A (en) * | 1989-07-25 | 1992-08-04 | E. I. Du Pont De Nemours And Company | Piezoelectric cell growth biosensing method using polymer-metabolic product complex interactions | 
| US5658732A (en) * | 1989-10-04 | 1997-08-19 | E. I. Du Pont De Nemours And Company | Assay method for biological target complexes on the surface of a biosensor | 
| US6010866A (en) * | 1990-04-27 | 2000-01-04 | Genzyme Corporation | Determination of analytes in biological fluids in the presence of substances interfering with assays therefor | 
| US5478756A (en) * | 1990-07-24 | 1995-12-26 | Fisons Plc | Chemical sensor for detecting binding reactions | 
| US5494639A (en) * | 1993-01-13 | 1996-02-27 | Behringwerke Aktiengesellschaft | Biosensor for measuring changes in viscosity and/or density of a fluid | 
| US5447845A (en) * | 1993-06-01 | 1995-09-05 | E. I. Du Pont De Nemours And Company | Analyte-responsive KTP composition and method | 
| AU673461B2 (en) * | 1993-10-13 | 1996-11-07 | Dade Behring Marburg Gmbh | Biosensor for measuring changes in viscosity and/or density | 
| US5455475A (en) * | 1993-11-01 | 1995-10-03 | Marquette University | Piezoelectric resonant sensor using the acoustoelectric effect | 
| US5728583A (en) * | 1993-11-11 | 1998-03-17 | Jeol, Ltd. | Determination of abnormal part of blood functions | 
| US5892144A (en) * | 1995-04-10 | 1999-04-06 | Behringwerke Aktiengesellschaft | Biosensor | 
| EP0737853A1 (en) * | 1995-04-10 | 1996-10-16 | BEHRINGWERKE Aktiengesellschaft | Biosensor | 
| US6630309B2 (en) | 1995-07-21 | 2003-10-07 | Biosensor Applications Sweden Ab | Determination of an analyte in a liquid medium | 
| US6207396B1 (en) | 1995-11-20 | 2001-03-27 | Microgenics Corporation | Immunoassay reagents and methods for determination of LSD and LSD metabolites | 
| US5843682A (en) * | 1995-11-20 | 1998-12-01 | Boehringer Mannheim Corporation | N-1-carboxyalkyl derivatives of LSD | 
| EP0781999A1 (en) | 1995-12-27 | 1997-07-02 | Behringwerke Ag | Mass-sensitive biosensors | 
| US6087187A (en) * | 1995-12-27 | 2000-07-11 | Dade Behring Marburg Gmbh | Mass-sensitive biosensors | 
| US6118124A (en) * | 1996-01-18 | 2000-09-12 | Lockheed Martin Energy Research Corporation | Electromagnetic and nuclear radiation detector using micromechanical sensors | 
| US5814525A (en) * | 1996-01-25 | 1998-09-29 | Sandia Corporation | Piezoelectric biosensor with a ladder polymer substrate coating | 
| US6033852A (en) * | 1996-09-27 | 2000-03-07 | University Of Maine | Monolithic piezoelectric sensor (MPS) for sensing chemical, biochemical and physical measurands | 
| US5932953A (en) * | 1997-06-30 | 1999-08-03 | Iowa State University Research Foundation, Inc. | Method and system for detecting material using piezoelectric resonators | 
| US6723524B1 (en) * | 1997-12-01 | 2004-04-20 | Nederlandse Organisatie Voor Toegepastnatuurwetenschappelijk Onderzoek Tno | Immunoassay method and kit | 
| US6016686A (en) * | 1998-03-16 | 2000-01-25 | Lockheed Martin Energy Research Corporation | Micromechanical potentiometric sensors | 
| RU2148259C1 (en) * | 1998-04-17 | 2000-04-27 | Ставропольский научно-исследовательский противочумный институт | Method for detecting macromolecules using biosensory device | 
| US6289286B1 (en) * | 1998-05-29 | 2001-09-11 | Biacore Ab | Surface regeneration of biosensors and characterization of biomolecules associated therewith | 
| US6167748B1 (en) | 1998-08-31 | 2001-01-02 | Lockheed Martin Energy Research Corporation | Capacitively readout multi-element sensor array with common-mode cancellation | 
| US7135295B1 (en) | 1999-01-25 | 2006-11-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Detection of small molecules by use of a piezoelectric sensor | 
| US6289717B1 (en) | 1999-03-30 | 2001-09-18 | U. T. Battelle, Llc | Micromechanical antibody sensor | 
| US7195909B2 (en) * | 1999-04-22 | 2007-03-27 | Akubio Limited | Measurement and use of molecular interactions | 
| US20070218534A1 (en) * | 1999-04-22 | 2007-09-20 | David Klenerman | Measurement and use of molecular interactions | 
| US20030194697A1 (en) * | 1999-04-22 | 2003-10-16 | David Klenerman | Measurement and use of molecular interactions | 
| US7763475B2 (en) | 1999-04-22 | 2010-07-27 | Inverness Medical Switzerland Gmbh | Measurement and use of molecular interactions | 
| US7105358B2 (en) | 1999-08-19 | 2006-09-12 | The Regents Of The University Of California | Apparatus and method for visually identifying micro-forces with a palette of cantilever array blocks | 
| US20020102743A1 (en) * | 1999-08-19 | 2002-08-01 | The Regents Of The University Of California | Apparatus and method for visually identifying micro-forces with a palette of cantilever array blocks | 
| US20030154149A1 (en) * | 2002-02-13 | 2003-08-14 | Dilip Gajendragadkar | System and method of creating and executing a restricted stock sale plan | 
| US20050003560A1 (en) * | 2003-06-05 | 2005-01-06 | Oakland Univesity | Piezoimmunosensor | 
| US8148170B2 (en) | 2003-06-05 | 2012-04-03 | Oakland University | Immunosensors: scFv-linker design for surface immobilization | 
| US7329536B2 (en) * | 2003-06-05 | 2008-02-12 | Oakland University | Piezoimmunosensor | 
| US20050124896A1 (en) * | 2003-08-25 | 2005-06-09 | Jacob Richter | Method for protecting implantable sensors and protected implantable sensors | 
| US20050063882A1 (en) * | 2003-09-16 | 2005-03-24 | Steris Inc. | Sensor for determining concentration of fluid sterilant | 
| US7232545B2 (en) | 2003-09-16 | 2007-06-19 | Steris Inc. | Sensor for determining concentration of fluid sterilant | 
| US7527766B2 (en) | 2004-05-12 | 2009-05-05 | Steris Corporation | Method for determining the efficiency of a vaporizer in a decontamination system | 
| US20080110240A1 (en) * | 2004-05-12 | 2008-05-15 | Steris Corporation | Method for determining the efficiency of a vaporizer in a decontamination system | 
| US20050252274A1 (en) * | 2004-05-12 | 2005-11-17 | Steris Inc. | Method and apparatus for determining the efficiency of a vaporizer in a decontamination system | 
| US7541002B2 (en) | 2004-05-12 | 2009-06-02 | Steris Corporation | Apparatus for determining the efficiency of a vaporizer in a decontamination system | 
| US7473551B2 (en) | 2004-05-21 | 2009-01-06 | Atonomics A/S | Nano-mechanic microsensors and methods for detecting target analytes | 
| US20080063574A1 (en) * | 2004-05-25 | 2008-03-13 | Steris Corporation | Apparatus for controlling the concentration of a sterilant chemical in a fluid | 
| US7611667B2 (en) | 2004-05-25 | 2009-11-03 | Steris Corporation | Apparatus for controlling the concentration of a sterilant chemical in a fluid | 
| US7955560B2 (en) | 2004-09-24 | 2011-06-07 | Steris Corporation | Apparatus for determining the concentration of chemical components in a liquid or gaseous system using multiple sensors | 
| US20080206105A1 (en) * | 2004-09-24 | 2008-08-28 | Steris Corporation | Apparatus for determining the concentration of chemical components in a liquid or gaseous system using multiple sensors | 
| US7431886B2 (en) | 2004-09-24 | 2008-10-07 | Steris Corporation | Method of monitoring operational status of sensing devices for determining the concentration of chemical components in a fluid | 
| US20060073077A1 (en) * | 2004-09-24 | 2006-04-06 | Steris, Inc. | Method and apparatus for determining the concentration of chemical components in a liquid or gaseous system using multiple sensors | 
| AU2005288712C1 (en) * | 2004-09-27 | 2010-06-03 | Microtech Medical Technologies Ltd | A method for protecting implantable sensors and protected implantable sensors | 
| AU2005288712B2 (en) * | 2004-09-27 | 2009-10-29 | Microtech Medical Technologies Ltd | A method for protecting implantable sensors and protected implantable sensors | 
| US20060105466A1 (en) * | 2004-11-12 | 2006-05-18 | Steris Inc. | Sensor for determining concentration of ozone | 
| US7464580B2 (en) | 2005-09-26 | 2008-12-16 | Oakland University | Ionic liquid high temperature gas sensors | 
| US20070068222A1 (en) * | 2005-09-26 | 2007-03-29 | Oakland University | Ionic liquid high temperature gas sensors | 
| US7886577B2 (en) | 2006-03-30 | 2011-02-15 | Oakland University | Devices with surface bound ionic liquids and method of use thereof | 
| US8375768B2 (en) | 2006-03-30 | 2013-02-19 | Oakland University | Ionic liquid thin layer sensor for electrochemical and/or piezoelectric measurements | 
| US20090293590A1 (en) * | 2006-03-30 | 2009-12-03 | Oakland University | Ionic liquid thin layer sensor for electrochemical and/or piezoelectric measurements | 
| US9366672B2 (en) | 2006-10-10 | 2016-06-14 | Oakland University | Microorganism detection and analysis using carbohydrate and lectin recognition | 
| US20080193965A1 (en) * | 2006-10-10 | 2008-08-14 | Oakland University | Microorganism detection and analysis using carbohydrate and lectin recognition | 
| US8088596B2 (en) | 2006-10-10 | 2012-01-03 | Oakland University | Method of microorganism detection using carbohydrate and lectin recognition | 
| US20090280509A1 (en) * | 2008-05-08 | 2009-11-12 | Samsung Electronics Co., Ltd. | Surface acoustic wave immunosensor for diagnosing allergy disease and method for diagnosing allergy disease using the same | 
| US20100238035A1 (en) * | 2009-03-19 | 2010-09-23 | Tangidyne Corporation | Detection device and method for detecting analyte | 
| US20130203182A1 (en) * | 2010-06-03 | 2013-08-08 | Phadia Ab | Method for decision support in allergy diagnosis | 
| WO2012076827A1 (en) | 2010-12-10 | 2012-06-14 | Universite De Technologie De Troyes | System and method for detecting biological or chemical species involving a qcm transducer | 
| US10161934B2 (en) | 2011-08-26 | 2018-12-25 | Aviana Molecular Technologies, Llc | Biocoated piezoelectric biosensor platform for point-of-care diagnostic use | 
| US10060916B2 (en) | 2013-11-21 | 2018-08-28 | Avails Medical, Inc. | Electrical biosensor for detecting a substance in a bodily fluid, and method and system for same | 
| US9377456B1 (en) * | 2014-12-30 | 2016-06-28 | Avails Medical, Inc. | Systems and methods for detecting a substance in bodily fluid | 
| US9766201B2 (en) | 2014-12-30 | 2017-09-19 | Avails Medical, Inc. | Systems and methods for detecting a substance in bodily fluid | 
| US9702847B2 (en) | 2014-12-30 | 2017-07-11 | Avails Medical, Inc. | Systems and methods for detecting a substance in bodily fluid | 
| WO2017005663A1 (en) * | 2015-07-03 | 2017-01-12 | Foundation For Research And Technology Hellas | Measurement of analyte with an acoustic wave sensor | 
| US10883135B2 (en) | 2015-08-25 | 2021-01-05 | Avails Medical, Inc. | Devices, systems and methods for detecting viable infectious agents in a fluid sample | 
| US10254245B2 (en) | 2016-01-25 | 2019-04-09 | Avails Medical, Inc. | Devices, systems and methods for detecting viable infectious agents in a fluid sample using an electrolyte-insulator-semiconductor sensor | 
| US12275982B2 (en) | 2016-05-31 | 2025-04-15 | Avails Medical, Inc. | Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives | 
| US10174356B2 (en) | 2016-05-31 | 2019-01-08 | Avails Medical, Inc. | Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives | 
| US11021732B2 (en) | 2016-05-31 | 2021-06-01 | Avails Medical, Inc. | Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives | 
| US11913058B2 (en) | 2016-05-31 | 2024-02-27 | Avails Medical, Inc. | Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives | 
| US12352714B2 (en) | 2016-12-13 | 2025-07-08 | Avails Medical, Inc. | Devices, systems and methods to detect the presence of ß-lactam antibiotic hydrolyzing bacteria in a sample | 
| US11385200B2 (en) | 2017-06-27 | 2022-07-12 | Avails Medical, Inc. | Apparatus, systems, and methods for determining susceptibility of microorganisms to anti-infectives | 
| US12276634B2 (en) | 2017-06-27 | 2025-04-15 | Avails Medical, Inc. | Apparatus, systems, and methods for determining susceptibility of microorganisms to anti-infectives | 
| US10889848B2 (en) | 2017-07-14 | 2021-01-12 | American Sterilizer Company | Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same | 
| US10900062B2 (en) | 2017-07-14 | 2021-01-26 | American Sterilizer Company | Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same | 
| US10876144B2 (en) | 2017-07-14 | 2020-12-29 | American Sterilizer Company | Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same | 
| US10948489B2 (en) * | 2017-07-19 | 2021-03-16 | Purdue Research Foundation | Method of detecting a substance | 
| US12275981B2 (en) | 2017-10-03 | 2025-04-15 | Avails Medical, Inc. | Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions | 
| US11655494B2 (en) | 2017-10-03 | 2023-05-23 | Avails Medical, Inc. | Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions | 
| US12422343B2 (en) | 2017-12-05 | 2025-09-23 | Avails Medical, Inc. | Apparatus, systems, and methods for preparing an output sample comprising a defined concentration of an infectious agent for downstream testing | 
| US12379373B2 (en) | 2018-12-03 | 2025-08-05 | Avails Medical, Inc. | Apparatus, systems, and methods for quantifying infectious agents | 
| CN114935647A (en) * | 2022-05-12 | 2022-08-23 | 石家庄和亚生物技术有限公司 | Method for quantitatively detecting candida albicans enolase antibody | 
Also Published As
| Publication number | Publication date | 
|---|---|
| EP0026215A4 (en) | 1981-08-31 | 
| EP0026215A1 (en) | 1981-04-08 | 
| CA1131341A (en) | 1982-09-07 | 
| WO1980002201A1 (en) | 1980-10-16 | 
| DE3070944D1 (en) | 1985-09-12 | 
| EP0026215B1 (en) | 1985-08-07 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| US4236893A (en) | Method for the assay of classes of antigen-specific antibodies | |
| US4314821A (en) | Sandwich immunoassay using piezoelectric oscillator | |
| US4242096A (en) | Immunoassay for antigens | |
| Gosslau et al. | Enzyme-linked immunosorbent microassay for quantification of specific antibodies to collagen type I, II, III | |
| US4925788A (en) | Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor | |
| US4757002A (en) | Method and kit for the estimation of serum immunoglobulin | |
| CA1146067A (en) | Solid phase immunoassay with labelled anti-hapten antibody | |
| EP0063810A1 (en) | New devices and kits for immunological analysis | |
| JP2599058B2 (en) | Class-specific immunoglobulin antibody immunoassay | |
| US6630309B2 (en) | Determination of an analyte in a liquid medium | |
| EP0223843A4 (en) | METHOD AND ELEMENT FOR DETECTION OF IMMUNE COMPOUNDS. | |
| CA1117009A (en) | Fc fragment of immunoglobulin bound to a carrier | |
| CA2250715A1 (en) | A method of detecting transmissible spongiform encephalopathies | |
| Gardies et al. | Feasibility of an immunosensor based upon capacitance measurements | |
| AU650232B2 (en) | Fluorometric assay of total IgE level and reagents therefor | |
| EP0350233B1 (en) | An article for performing immunological assays utilizing organic dyes and methods for producing and utilizing same | |
| JPS6120815B2 (en) | ||
| US4753893A (en) | Method and article for detection of immune complexes | |
| CA2001253C (en) | Process for the determination of antibodies which are class-specific for an antigen and a reagent for carrying out the process | |
| CA2047742A1 (en) | Method and diagnostic test kit for detection of anti-cardiolipin | |
| US5843794A (en) | Technique for the prevention of false positive reactions in immunological testing due to C1 and C1q components of the complement and method for screening for rheumatic factor | |
| JPH0325366A (en) | Specific antibody measurement method | |
| JPH04233462A (en) | Immunological quantitative analysis | |
| Hamilton | Immunological methods in the diagnostic allergy clinical and research laboratory | |
| JP3499293B2 (en) | Massage method and evaluation method of massage fee |